<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">41792</article-id><article-id pub-id-type="doi">10.7554/eLife.41792</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>SUMO peptidase ULP-4 regulates mitochondrial UPR-mediated innate immunity and lifespan extension</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-122445"><name><surname>Gao</surname><given-names>Kaiyu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-98744"><name><surname>Li</surname><given-names>Yi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-98745"><name><surname>Hu</surname><given-names>Shumei</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-86329"><name><surname>Liu</surname><given-names>Ying</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3328-026X</contrib-id><email>ying.liu@pku.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, and Peking-Tsinghua Center for Life Sciences</institution><institution>Peking University</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Academy for Advanced Interdisciplinary Studies</institution><institution>Peking University</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Zhang</surname><given-names>Hong</given-names></name><role>Reviewing Editor</role><aff><institution>Institute of Biophysics, Chinese Academy of Sciences</institution><country>China</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dikic</surname><given-names>Ivan</given-names></name><role>Senior Editor</role><aff><institution>Goethe University Frankfurt</institution><country>Germany</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>15</day><month>01</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>8</volume><elocation-id>e41792</elocation-id><history><date date-type="received" iso-8601-date="2018-09-06"><day>06</day><month>09</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2019-01-02"><day>02</day><month>01</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Gao et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Gao et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-41792-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.41792.001</object-id><p>Animals respond to mitochondrial stress with the induction of mitochondrial unfolded protein response (UPR<sup>mt</sup>). A cascade of events occur upon UPR<sup>mt</sup> activation, ultimately triggering a transcriptional response governed by two transcription factors: DVE-1 and ATFS-1. Here we identify SUMO-specific peptidase ULP-4 as a positive regulator of <italic>C. elegans</italic> UPR<sup>mt</sup> to control SUMOylation status of DVE-1 and ATFS-1. SUMOylation affects these two axes in the transcriptional program of UPR<sup>mt</sup> with distinct mechanisms: change of DVE-1 subcellular localization vs. change of ATFS-1 stability and activity. Our findings reveal a post-translational modification that promotes immune response and lifespan extension during mitochondrial stress.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.41792.002</object-id><title>eLife digest</title><p>Most animal cells carry compartments called mitochondria. These tiny powerhouses produce the energy that fuels many life processes, but they also store important compounds and can even cause an infected or defective cell to kill itself. For a cell, keeping its mitochondria healthy is often a matter of life and death: failure to do so is linked with aging, cancer or diseases such as Alzheimer’s.</p><p>The cell uses a surveillance program called the mitochondrial unfolded protein response to assess the health of its mitochondria. If something is amiss, the cell activates specific mechanisms to fix the problem, which involves turning on specific genes in its genome.</p><p>A protein named ULP-4, which is found in the worm <italic>Caenorhabditis elegans</italic> but also in humans, participates in this process. This enzyme cuts off chemical ‘tags’ known as SUMO from proteins. Adding and removing these labels changes the place and role of a protein in the cell. However, it was still unclear how ULP-4 played a role in the mitochondrial unfolded protein response.</p><p>Here, Gao et al. show that when mitochondria are in distress, ULP-4 removes SUMO from DVE-1 and ATFS-1, two proteins that control separate arms of the mitochondrial unfolded protein response. Without SUMO tags, DVE-1 can relocate to the area in the cell where it can turn on genes that protect and repair mitochondria; meanwhile SUMO-free ATFS-1 becomes more stable and can start acting on the genome. Finally, the experiments show that removing SUMO on DVE-1 and ATFS-1 is essential to keep the worms healthy and with a long lifespan under mitochondrial stress.</p><p>The experiments by Gao et al. show that the mitochondrial unfolded protein response relies, at least in part, on SUMO tags. This knowledge opens new avenues of research, and could help fight diseases that emerge when mitochondria fail.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>mitochondria</kwd><kwd>stress response</kwd><kwd>sumoylation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>C. elegans</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>91854205</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Ying</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31422033</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Ying</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><award-id>55008739</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Ying</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002855</institution-id><institution>Ministry of Science and Technology of the People's Republic of China</institution></institution-wrap></funding-source><award-id>2017YFA0504000973</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Ying</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>SUMOylation regulates mitochondrial UPR signaling through modulation of transcription factors DVE-1 and ATFS-1.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The ability of an organism to cope with an ever-changing and challenging environment lies in its ability to activate stress responses. Failure to appropriately respond to different stresses and maintain cellular and organismal homeostasis could result in multiple diseases including metabolic and neurodegenerative disorders (<xref ref-type="bibr" rid="bib16">Jovaisaite et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Lee and Ozcan, 2014</xref>; <xref ref-type="bibr" rid="bib41">Wang and Kaufman, 2012</xref>). Animals respond to mitochondrial stress with the induction of mitochondrial unfolded protein response (UPR<sup>mt</sup>), a surveillance program that monitors mitochondrial function and initiates mitochondria-to-nucleus crosstalk to maintain mitochondrial protein-folding homeostasis (<xref ref-type="bibr" rid="bib2">Benedetti et al., 2006</xref>; <xref ref-type="bibr" rid="bib44">Yoneda et al., 2004</xref>) and coordinate the expression of electron transport chain (ETC) components in mitochondrial and nuclear genomes (<xref ref-type="bibr" rid="bib15">Houtkooper et al., 2013</xref>). UPR<sup>mt</sup> also elicits global changes to reprogram metabolism (<xref ref-type="bibr" rid="bib27">Nargund et al., 2015</xref>; <xref ref-type="bibr" rid="bib26">Nargund et al., 2012</xref>), activate immune responses (<xref ref-type="bibr" rid="bib21">Liu et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Melo and Ruvkun, 2012</xref>; <xref ref-type="bibr" rid="bib30">Pellegrino et al., 2014</xref>) and extend lifespan (<xref ref-type="bibr" rid="bib7">Durieux et al., 2011</xref>; <xref ref-type="bibr" rid="bib23">Merkwirth et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Tian et al., 2016</xref>).</p><p>UPR<sup>mt</sup> signaling ultimately activates a transcriptional response governed by two transcription factors: ATFS-1 and DVE-1. ATFS-1 contains an N-terminal mitochondrial targeting sequence and a C-terminal nuclear localization sequence. Under normal condition, ATFS-1 is imported into mitochondria, where it is degraded by mitochondrial protease LON. During mitochondrial stress, mitochondrial import efficiency is impaired, resulting in nuclear accumulation of ATFS-1 (<xref ref-type="bibr" rid="bib26">Nargund et al., 2012</xref>). ATFS-1 controls approximately half of the mitochondrial stress response genes, including those encoding mitochondrial-specific chaperones, proteases and immune response genes (<xref ref-type="bibr" rid="bib26">Nargund et al., 2012</xref>). ATFS-1 also regulates genes involved in metabolic reprogramming, such as those functioning in glycolysis (<xref ref-type="bibr" rid="bib27">Nargund et al., 2015</xref>). Another axis of the UPR<sup>mt</sup> transcriptional program relies on DVE-1, a homeobox transcription factor homologous to human SATB1/SATB2. Upon mitochondrial perturbation, DVE-1 translocates from cytosol to nucleus, binds to the open-up chromatins devoid of H3K9me2, and initiates the transcription of mitochondrial stress response genes (<xref ref-type="bibr" rid="bib13">Haynes et al., 2007</xref>; <xref ref-type="bibr" rid="bib39">Tian et al., 2016</xref>). While several core components of UPR<sup>mt</sup> have been identified, the regulation, especially post-translational regulation of these components has not been reported.</p><p>The Small Ubiquitin-like Modifier (SUMO) post-translational modifies a large number of proteins that function in diverse biological processes, including transcription, chromatin remodeling, DNA repair and mitochondrial dynamics (<xref ref-type="bibr" rid="bib11">Gill, 2004</xref>; <xref ref-type="bibr" rid="bib12">Hay, 2005</xref>; <xref ref-type="bibr" rid="bib14">Hendriks et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Prudent et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Wasiak et al., 2007</xref>; <xref ref-type="bibr" rid="bib43">Yeh et al., 2000</xref>). Growing evidence suggests that rather than modifying a single protein, SUMO often targets multiple proteins within a complex, or within a pathway (<xref ref-type="bibr" rid="bib4">Chymkowitch et al., 2015</xref>; <xref ref-type="bibr" rid="bib14">Hendriks et al., 2014</xref>). Similar to ubiquitination, conjugation of SUMO to its substrates involves an enzymatic cascade including an E1 activating enzyme, an E2 conjugating enzyme and E3 ligases that determine the specificity (<xref ref-type="bibr" rid="bib10">Flotho and Melchior, 2013</xref>). SUMOylation is also a dynamic process, which can be reversed by a family of conserved Sentrin/SUMO-specific proteases (SENPs) (<xref ref-type="bibr" rid="bib25">Mukhopadhyay and Dasso, 2007</xref>). In <italic>C. elegans</italic>, the SENP family consists of four SUMO proteases (ubiquitin-like proteases, ULPs) ULP-1, ULP-2, ULP-4 and ULP-5. Among them, ULP-2 has been reported to deSUMOylate E-cadherin and promotes its recruitment to adherens junctions (<xref ref-type="bibr" rid="bib40">Tsur et al., 2015</xref>). Moreover, ULP-4 has been reported to deSUMOylate HMGS-1 to control mevalonate pathway activity during aging (<xref ref-type="bibr" rid="bib33">Sapir et al., 2014</xref>).</p><p>Aberrant activity of SUMOylation drastically affects cellular homeostasis and has been linked with many diseases (<xref ref-type="bibr" rid="bib10">Flotho and Melchior, 2013</xref>; <xref ref-type="bibr" rid="bib24">Mo et al., 2005</xref>; <xref ref-type="bibr" rid="bib34">Sarge and Park-Sarge, 2009</xref>; <xref ref-type="bibr" rid="bib36">Seeler et al., 2007</xref>). It has been reported that SUMO could covalently modify Drp1, a protein essential for mitochondrial dynamics (<xref ref-type="bibr" rid="bib31">Prudent et al., 2015</xref>). In addition, SUMOylation of a pathogenic fragment of Huntingtin, a PolyQ-repeats protein that specifically binds to the outer membrane of mitochondria and impairs mitochondrial function, has been reported to exacerbate neurodegeneration in a <italic>Drosophila</italic> Huntington’s disease model (<xref ref-type="bibr" rid="bib5">Costa and Scorrano, 2012</xref>; <xref ref-type="bibr" rid="bib28">Panov et al., 2002</xref>; <xref ref-type="bibr" rid="bib37">Steffan et al., 2004</xref>).</p><p>In the present study, we find that under mitochondrial stress, SUMO-specific peptidase ULP-4 is required to deSUMOylate DVE-1 and ATFS-1 to activate UPR<sup>mt</sup> in <italic>C. elegans</italic>. ULP-4 is also required to promote UPR<sup>mt</sup>-mediated innate immunity and lifespan extension. Our results reveal an essential and unexplored function of post-translational regulation in UPR<sup>mt</sup> signaling.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>SUMO-specific peptidase ULP-4 is required for the activation of UPR<sup>mt</sup></title><p>Previously, we have performed a genome-wide RNAi screen to identify genes that are required for the activation of mitochondrial unfolded protein response (UPR<sup>mt</sup>) in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib21">Liu et al., 2014</xref>). <italic>ulp-4</italic>, a gene encoding ortholog of SUMO-specific peptidase in <italic>C. elegans</italic>, is one of the hits from our primary screen. RNAi of <italic>ulp-4</italic> impaired the activation of UPR<sup>mt</sup> that is induced by mitochondrial inhibitor antimycin A, or RNAi of nuclear encoded mitochondrial gene <italic>spg-7</italic> (mitochondrial metalloprotease) (<xref ref-type="fig" rid="fig1">Figure 1A–B</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). RNAi of <italic>cco-1</italic> (nuclear-encoded cytochrome c oxidase-1 subunit) is also widely used to disrupt mitochondrial function and activate UPR<sup>mt</sup> (<xref ref-type="bibr" rid="bib7">Durieux et al., 2011</xref>; <xref ref-type="bibr" rid="bib26">Nargund et al., 2012</xref>; <xref ref-type="bibr" rid="bib30">Pellegrino et al., 2014</xref>). Consistently, deficiency of <italic>ulp-4</italic> also suppressed the induction of endogenous mitochondrial chaperone genes <italic>hsp-6</italic> and <italic>hsp-60</italic> under <italic>cco-1</italic> RNAi (<xref ref-type="fig" rid="fig1">Figure 1C</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Notably, transcript level of <italic>ulp-4</italic> was also elevated during mitochondrial stress (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). In contrast, <italic>ulp-4</italic> RNAi did not affect the induction of endoplasmic reticulum (ER) stress reporter <italic>hsp-4p::gfp</italic> nor heat shock stress reporter <italic>hsp-16.2p::gfp</italic> (<xref ref-type="fig" rid="fig1">Figure 1D–E</xref>). In addition, worms treated with <italic>ulp-4</italic> RNAi were still able to induce the expression of endogenous <italic>hsp-4</italic> or <italic>hsp-16.2</italic> during ER or heat shock stress (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). RNAi of <italic>ulp-4</italic> from L1 stage only delayed worm development a bit (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). To further exclude the possibility that the suppression of UPR<sup>mt</sup> by <italic>ulp-4</italic> RNAi is due to developmental delay, we also treated worms with <italic>ulp-4</italic> RNAi starting at L4 stage and observed the reduction of UPR<sup>mt</sup> as well (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). Overexpression of ULP-4 in <italic>ulp-4</italic> RNAi worms rescued UPR<sup>mt</sup> activation (<xref ref-type="fig" rid="fig1">Figure 1G</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>). Lastly, we crossed an <italic>ulp-4(tm1597)</italic> mutant allele that lacks 404nt in the promoter region of <italic>ulp-4</italic> with <italic>hsp-6p::gfp</italic> reporter, and showed that the induction of UPR<sup>mt</sup> was also impaired in <italic>ulp-4</italic> mutants (<xref ref-type="fig" rid="fig1">Figure 1H–I</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>).</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.41792.003</object-id><label>Figure 1.</label><caption><title>SUMO-specific peptidase ULP-4 is required for the activation of UPR<sup>mt</sup>.</title><p>(<bold>A</bold>) <italic>hsp-6p::gfp</italic> animals fed with control RNAi (top) or <italic>ulp-4</italic> RNAi (bottom) were untreated, or treated with antimycin or <italic>spg-7</italic> RNAi. Scale bar is 200 μm in this study unless otherwise indicated. Secondary RNAi was added 24 hr later after first RNAi unless otherwise indicated. Antimycin was added 48 hr later after first RNAi unless otherwise indicated. (<bold>B</bold>) Immunoblot of GFP expression in untreated <italic>hsp-6p::gfp</italic> worms, or <italic>hsp-6p::gfp</italic> worms treated with antimycin or <italic>spg-7</italic> RNAi. (<bold>C</bold>) Quantitative PCR of endogenous <italic>hsp-6</italic> mRNA levels. (<bold>D–E</bold>) <italic>hsp-4p::gfp</italic> (<bold>D</bold>) or <italic>hsp-16.2p::gfp</italic> (<bold>E</bold>) animals on control or <italic>ulp-4</italic> RNAi were treated with tunicamycin (<bold>D</bold>) or heat-shocked (<bold>E</bold>). (<bold>F</bold>) Quantitative PCR of endogenous <italic>hsp-16.2</italic> and <italic>hsp-4</italic> mRNA levels. (<bold>G</bold>) <italic>hsp-6p::gfp</italic> or <italic>hsp-6p::gfp; rpl-28p::ulp-4</italic> (<italic>ulp-4</italic> overexpression, OE) animals fed with control or <italic>ulp-4</italic> RNAi were untreated or treated with <italic>cco-1</italic> RNAi. Overexpressed <italic>ulp-4</italic> is codon optimized. (<bold>H</bold>) <italic>hsp-6p::gfp</italic> or <italic>ulp-4(tm1597); hsp-6p::gfp</italic> animals were fed with control or <italic>cco-1</italic> RNAi. (<bold>I</bold>) Quantitative PCR of <italic>ulp-4</italic> mRNA level in wild-type or <italic>ulp-4(tm1597)</italic> animals. (<bold>J</bold>) Quantitative PCR of endogenous <italic>ulp-1,2,4,5</italic> mRNA levels under each respective RNAi. (<bold>K</bold>) <italic>hsp-6p::gfp</italic> animals fed with control or <italic>ulp-1,2,4,5</italic> RNAi were treated with antimycin or <italic>spg-7</italic> RNAi. Error bars show standard deviation. Student’s t-test, ns not significant, **p&lt;0.002 and ***p&lt;0.0002. All experiments in this paper, if not specifically indicated, have been repeated for at least three times.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41792-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41792.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>SUMO-specific peptidase ULP-4 is required for the activation of UPR<sup>mt</sup>.</title><p>(<bold>A–C</bold>) Quantitative PCR of <italic>spg-7</italic> (<bold>A</bold>), <italic>hsp-60</italic> (<bold>B</bold>) and <italic>ulp-4</italic> (<bold>C</bold>) mRNA levels under indicated RNAi. (<bold>D</bold>) Statistic results for developmental stages of worm fed with control or <italic>ulp-4</italic> RNAi at 20°C for 60 hr, n &gt; 80. (<bold>E</bold>) L4 stage <italic>hsp-6p::gfp</italic> animals were fed with control or <italic>ulp-4</italic> RNAi for 24 hr before antimycin treatment. Representative fluorescent images were taken 24 hr after antimycin treatment. (<bold>F–G</bold>) Statistic result of relative gfp intensity in <xref ref-type="fig" rid="fig1">Figure 1C</xref> (<bold>F</bold>) and 1D (<bold>G</bold>). Student’s t-test. Error bars indicate standard deviation. ns not significant, *p&lt;0.05, **p&lt;0.002 and ***p&lt;0.0002.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41792-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41792.005</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Sequence alignment of worm ULP proteins.</title><p>The alignment was performed by MAFFT (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/Tools/msa/mafft/">https://www.ebi.ac.uk/Tools/msa/mafft/</ext-link>). The catalytic domain of ULP-4 is highlighted in red.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41792-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41792.006</object-id><label>Figure 1—figure supplement 3.</label><caption><title>Deficiency of <italic>smo-1</italic> or SUMO conjugating enzymes enhances UPR<sup>mt</sup>.</title><p>(<bold>A</bold>) <italic>hsp-6p::gfp</italic> animals on control, <italic>aos-1</italic> or <italic>ubc-9</italic> RNAi were untreated, or treated with antimycin or <italic>spg-7</italic> RNAi.(<bold>B</bold>) Statistic result of relative gfp intensity in (<bold>A</bold>). (<bold>C–D</bold>) Quantitative PCR testing RNAi efficiency of <italic>aos-1</italic>, <italic>ubc-9</italic> (<bold>B</bold>) and <italic>smo-1</italic> (<bold>C</bold>) RNAi. (<bold>E</bold>) Representative fluorescent images (upper panel) and statistic result of relative gfp intensity (lower panel) for <italic>hsp-6::gfp</italic> animals fed with indicated RNAi. (<bold>F</bold>) Representative fluorescent images of <italic>hsp-6p::gfp</italic> animals fed with indicated RNAi and then treated with antimycin. (<bold>G</bold>) Statistic result of relative gfp intensity in (<bold>F</bold>). Student’s t-test. Error bars indicate standard deviation. ns not significant, **p&lt;0.002 and ***p&lt;0.0002.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41792-fig1-figsupp3-v2.tif"/></fig></fig-group><p>To see if other SUMO peptidases have similar effects to regulate UPR<sup>mt</sup>, we treated <italic>C. elegans</italic> with <italic>ulp-1</italic>, <italic>2</italic>, or <italic>5</italic> RNAi (<xref ref-type="fig" rid="fig1">Figure 1J</xref>) and tested for their abilities to induce UPR<sup>mt</sup>. Deficiency of <italic>ulp-1</italic>, <italic>2</italic>, or <italic>5</italic> failed to suppress antimycin- or <italic>spg-7</italic> RNAi-induced UPR<sup>mt</sup> (<xref ref-type="fig" rid="fig1">Figure 1K</xref>), suggesting a specific role of <italic>ulp-4</italic> in mediating UPR<sup>mt</sup>. Sequence alignment (<xref ref-type="bibr" rid="bib17">Katoh and Standley, 2013</xref>) of <italic>ulp-1</italic>, <italic>2</italic>, <italic>4</italic> and <italic>5</italic> revealed that the only conserved region among them is the catalytic domain (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Thus, the specificity of ULP-4 in UPR<sup>mt</sup> signaling might be due to its ability to specifically interact with other protein components in UPR<sup>mt</sup> pathway.</p><p>Conversely, RNAi of the E1 SUMO activating enzyme <italic>aos-1</italic> or the E2 SUMO conjugating enzyme <italic>ubc-9</italic> in <italic>C. elegans</italic> induced UPR<sup>mt</sup> more potently (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A–C</xref>). Moreover, RNAi of <italic>smo-1</italic>, the only SUMO ortholog gene in <italic>C. elegans</italic>, induced only weak UPR<sup>mt</sup> under unstressed condition (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3D–E</xref>). However, upon mitochondrial stress, <italic>smo-1</italic> RNAi further activated UPR<sup>mt</sup> (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3F–G</xref>). More importantly, <italic>smo-1</italic> RNAi rescued <italic>ulp-4</italic> deficiency-suppressed UPR<sup>mt</sup> (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3F–G</xref>). Taken together, these results suggest that ULP-4 plays a specific role to mediate mitochondrial stress response through its SUMO peptidase activity.</p></sec><sec id="s2-2"><title>ULP-4 deSUMOylates DVE-1 at K327 residue during mitochondrial stress</title><p>To understand the molecular mechanism of ULP-4 in mediating UPR<sup>mt</sup>, we sought to identify its protein targets. We first performed a cherry-picked yeast two-hybrid screen to test if ULP-4 could interact with known UPR<sup>mt</sup> pathway components. We found that DVE-1, a homeodomain-containing transcription factor in UPR<sup>mt</sup> (<xref ref-type="bibr" rid="bib13">Haynes et al., 2007</xref>), interacted with ULP-4 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Notably, DVE-1 could specifically interact with ULP-4, but not ULP-2 or ULP-5 (Note: overexpression of ULP-1 in yeast is lethal) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Consistently, <italic>smo-1</italic> is one of the top hits from our yeast two-hybrid screen with DVE-1 as bait (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.41792.007</object-id><label>Figure 2.</label><caption><title>ULP-4 deSUMOylates DVE-1 at K327 residue during mitochondrial stress.</title><p>(<bold>A</bold>) Yeast two-hybrid result of ULP-4 and DVE-1 interaction. AH109 strain was transformed with Gal4-BD-ULP-4 and empty Gal4-AD or Gal4-AD-DVE-1 plasmids. –TL, tryptophan and leucine dropout agar media plates. –THLA, tryptophan, leucine, histidine and adenine dropout agar media plates. (<bold>B</bold>) Diagrams showing possible mechanisms for SMO-1 and prey protein interaction in yeast two-hybrid assay. (<bold>C</bold>) Yeast two-hybrid assay of the interaction between wild-type, K327R, K461R, K465R or K355R DVE-1 and SMO-1. SMO-1 GG’, residues after C-terminal di-glycine were deleted. SMO-1ΔGG, di-glycine residues in SMO-1 were deleted. (<bold>D</bold>) Predicted SUMOylation sites of DVE-1 using GPS-SUMO web service (<ext-link ext-link-type="uri" xlink:href="http://sumosp.biocuckoo.org/online.php">http://sumosp.biocuckoo.org/online.php</ext-link>). (<bold>E</bold>) In vivo SUMOylation assay for DVE-1. Myc-tagged wild-type DVE-1 or DVE-1 K327R, SMO-1 and E2 SUMO conjugating enzyme UBC9 were expressed in 293 T cells. (<bold>F</bold>) DVE-1 SUMOylation in worms. DVE-1::GFP or DVE-1 K327R::GFP driven by <italic>dve-1</italic> promotor were expressed in worms. (<bold>G</bold>) Yeast three-hybrid assay of DVE-1 deSUMOylation. Constitutive Gal4-BD-DVE-1 expression and inducible ULP-4/ULP-5 expression elements were cloned into pBridge. ULP-4/5 was induced when methionine was dropout. –MTHL, methionine, tryptophan, leucine and histidine dropout agar plates. (<bold>H</bold>) Immunoblot of DVE-1 SUMOylation. L4 stage <italic>dve-1p::dve-1::3xmyc-6xhis</italic> worms or <italic>dve-1p::dve-1:: 3xmyc-6xhis; hsp-16.2p::ulp-4::gfp</italic> worms were heat shocked at 37°C for 1 hr, and cultured at 20°C for 8 hr before immunoprecipitation. (<bold>I</bold>) In vivo deSUMOylation assay for DVE-1. Myc-tagged ULP-4 C48 domain, SMO-1 and E2 SUMO conjugating enzyme UBC9 were expressed in 293 T cells. (<bold>J</bold>) <italic>hsp-6p::gfp</italic> or <italic>dve-1</italic> K327R; <italic>hsp-6p::gfp</italic> animals fed with control or <italic>ulp-4</italic> RNAi were treated with control, <italic>atp-2</italic> or <italic>cco-1</italic> RNAi.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41792-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41792.008</object-id><label>Figure 2—figure supplement 1.</label><caption><title>DVE-1 interacts with ULP-4 and SMO-1 in yeast two-hybrid assay.</title><p>(<bold>A</bold>) Yeast two-hybrid result of DVE-1 and ULPs. (<bold>B</bold>) Screen hits of yeast two-hybrid experiment with <italic>dve-1</italic> as bait. Gal4-BD-<italic>dve-1</italic> vector and Gal4-AD vector containing worm cDNAs were transformed in yeast. Clones grew on –THLA plates were picked and sequenced. Genes that have been identified more than twice were listed. (<bold>C</bold>) SMO-1 covalently modifies DVE-1. SMO-1 Δ GG: SMO-1 deleted with C-terminal di-glycine. (<bold>D</bold>) Immunoblot of SUMOylated DVE-1 in N2 or DVE-1::GFP worms with indicated RNAi. (<bold>E</bold>) SMO-1 interacts with DVE-1 301–468. Full-length (FL) DVE-1 or DVE-1 fragments 1–150, 151–300 and 301–468 are tested in yeast two-hybrid assay. (<bold>F</bold>) Immunoprecipitation and western blotting to detect SUMOylation of DVE-1 295–354. * indicates nonspecific band. ** indicates Igg light chain. (<bold>G</bold>) Quantitative PCR testing RNAi efficiency of <italic>cco-1</italic> or <italic>atp-2</italic> RNAi. Student’s t-test. Error bars indicate standard deviation. ns not significant, **p&lt;0.002 and ***p&lt;0.0002.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41792-fig2-figsupp1-v2.tif"/></fig></fig-group><p>Four possible mechanisms may explain the interaction between SMO-1 and a prey protein in the yeast two-hybrid experiment (<xref ref-type="fig" rid="fig2">Figure 2B</xref>): (I) SMO-1 covalently modifies the prey; (II) SMO-1 modifies an adaptor protein, which interacts with the prey; (III) SMO-1 non-covalently interacts with the prey; (IV) SMO-1 non-covalently interacts with an adaptor protein, which associates with the prey. To identify which mechanism explains our result (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), we deleted C-terminal tail of SMO-1 to expose a conserved di-glycine motif (GG’: active form) or deleted the di-glycine motif to inactivate SMO-1 (ΔGG: inactive form). Only wild type SMO-1 or SMO-1 GG’, but not SMO-1 ΔGG, interacted with DVE-1 (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>), indicating that SMO-1 either covalently modifies DVE-1, or covalently modifies an adaptor protein that associates with DVE-1.</p><p>SUMOylated DVE-1 could be detected in worms, the level of which was elevated under <italic>ulp-4</italic> RNAi (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). We therefore used GPS-SUMO web service, which predicts SUMOyaltion sites of a protein, to identify several lysine residues of DVE-1 that could potentially be SUMOylated (<xref ref-type="fig" rid="fig2">Figure 2D</xref>) (<xref ref-type="bibr" rid="bib32">Ren et al., 2009</xref>; <xref ref-type="bibr" rid="bib45">Zhao et al., 2014</xref>). To further map the SUMOylation site of DVE-1, we first tested the interaction between SMO-1 and fragments of DVE-1 in the yeast two-hybrid experiment. We found that DVE-1 301–468 associated with SMO-1 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>), suggesting that SUMOylation site may resides in 301–468 amino acids of DVE-1. We then employed site-direct mutagenesis to mutate K327, K461 or K465 residue of DVE-1 to arginine, and tested for its ability to associate with SMO-1. K327R, but not other mutations, abolished SMO-1-DVE-1 interaction (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Furthermore, SUMOylation of DVE-1 could be detected when we expressed wild type, but not DVE-1 K327R, with SMO-1 and E2 conjugating enzyme UBC9 in 293 T cells (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). We also noted that the size shift of SUMOylated DVE-1 was about the molecular weight of two EGFP-SMO-1. To exclude the possibility that DVE-1 has another SUMOylation sites in addition of K327, we expressed a fragment of DVE-1 (295–354), which contains only one lysine residue (K327) in this polypeptide in 293 T cells. We found that the size shift of DVE-1 295–354 is corresponding to di-SMO-1 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>), suggesting that DVE-1 only contains one SUMOylation site. Consistently, SUMOylation of DVE-1 on K327 residue was also observed in <italic>C. elegans</italic> (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Taken together, these results suggested that SMO-1 covalently modifies K327 residue of DVE-1.</p><p>To test if ULP-4 could directly deSUMOylate DVE-1, we employed a yeast three-hybrid experiment to induce the expression of ULP-4 or ULP-5 in yeasts. The expression of ULP-4 or ULP-5 was driven by a <italic>met17</italic> promoter, which could be induced when growth media is deficient for methionine.Induction of ULP-4, but not ULP-5, prevented yeast growth caused by SMO-1-DVE-1 interaction (<xref ref-type="fig" rid="fig2">Figure 2G</xref>), suggesting that ULP-4 may removes SUMO moiety from DVE-1. Overexpression of ULP-4 in worms decreased SUMOylation level of DVE-1 (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). In addition, expression of ULP-4 C48, the catalytic domain of ULP-4 (<xref ref-type="bibr" rid="bib20">Letunic and Bork, 2018</xref>) in 293 T cells could deSUMOylate DVE-1 in mammalian cells (<xref ref-type="fig" rid="fig2">Figure 2I</xref>). Lastly, if during mitochondrial stress, ULP-4 is indeed required to deSUMOylate DVE-1, mutation of K327 to arginine that prevents DVE-1 SUMOylation would bypass the requirement of ULP-4 for UPR<sup>mt</sup> induction. Indeed, we found that a CRISPR/Cas9 knock-in strain with DVE-1 K327R mutation bypassed the requirement of <italic>ulp-4</italic> and was capable to activate UPR<sup>mt</sup> under <italic>ulp-4</italic> RNAi (<xref ref-type="fig" rid="fig2">Figure 2J</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>).</p></sec><sec id="s2-3"><title>SUMOylation affects the subcellular localization of DVE-1</title><p>We next aimed to understand how SUMOylation affects DVE-1 function. During mitochondrial stress, DVE-1 translocates from cytosol to nucleus (<xref ref-type="bibr" rid="bib13">Haynes et al., 2007</xref>; <xref ref-type="bibr" rid="bib39">Tian et al., 2016</xref>) (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). Inactivation of <italic>ulp-4</italic> by RNAi abolished the nuclear accumulation of DVE-1 in <italic>cco-1</italic> RNAi-treated worms (<xref ref-type="fig" rid="fig3">Figure 3A–C</xref>). Conversely, overexpression of ulp-4 increased the nuclear accumulation of DVE-1 (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). More importantly, we found that the induction of UPR<sup>mt</sup> correlated well with DVE-1 subcellular localization. When we fed worms with <italic>ulp-4</italic> RNAi for one generation and treated their progeny with <italic>ulp-4</italic> RNAi for twenty-four hours to allow efficient <italic>ulp-4</italic> knockdown, and then fed animals with <italic>cco-1</italic> RNAi, we observed cytosolic accumulation of DVE-1 and suppression of UPR<sup>mt</sup> (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). However, when we treated progeny with a mixture of <italic>ulp-4</italic> and <italic>cco-1</italic> RNAi, which induced mitochondrial stress before <italic>ulp-4</italic> was efficiently knocked down, DVE-1 was still able to translocate to the nucleus and induce UPR<sup>mt</sup> (<xref ref-type="fig" rid="fig3">Figure 3E</xref>).</p><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.41792.009</object-id><label>Figure 3.</label><caption><title>SUMOylation affects the subcellular localization of DVE-1.</title><p>(<bold>A</bold>) Representative fluorescent images of <italic>dve-1p::dve-1::gfp</italic> animals fed with indicated RNAi. Blue arrows indicate that DVE-1::GFP remains in the nucleus. Red arrows indicate that DVE-1::GFP localizes in the cytosol. Scale bar is 100 μm. (<bold>B</bold>) Percentage of DVE-1::GFP in cytosol with indicated RNAi. Student’s t-test, ***p&lt;0.0002. Error bars indicate standard deviation. (<bold>C</bold>) Representative fluorescent images of <italic>dve-1p::dve-1::gfp</italic> animals fed with control or <italic>ulp-4</italic> RNAi. Scale bar is 10 μm. (<bold>D</bold>) Representative fluorescent images (left) and statistic result (right) for nuclear accumulation of DVE-1 in <italic>dve-1p::dve-1::gfp</italic> animals with or without <italic>ulp-4</italic> overexpression. (<bold>E</bold>) Induction of UPR<sup>mt</sup> correlates with nuclear accumulation of DVE-1. <italic>dve-1p::dve-1::gfp</italic> and <italic>hsp-6p::gfp</italic> P0 animals were fed with <italic>ulp-4</italic> RNAi. <italic>dve-1p::dve-1::gfp</italic> (left) or <italic>hsp-6p::gfp</italic> (right) animals were cultured with <italic>ulp-4</italic> RNAi for one generation, and F1s were then treated with indicated RNAi starting at L1 stage. Scale bar is 10 μm (left) and 200 μm (right). The number indicates the proportion of animals with DVE-1::GFP in cytosol. Numbers indicate Mean ±standard deviation. N = 3 biological replicates, n &gt; 100 worms each replicate. (<bold>F</bold>) DVE-1 K327R constitutively localizes in the nucleus, even under <italic>ulp-4</italic> RNAi. The number indicates the proportion of animals with DVE-1::GFP in cytosol. Numbers indicate Mean ±standard deviation. N = 3 biological replicates, n &gt; 100 worms per replicate. (<bold>G</bold>) Fusion of SMO-1 to DVE-1 to mimic its SUMOylated form results in DVE-1 expression in the cytosol. Worms were observed 2 hr after 1 hr heat shock at 37°C. The number indicates the proportion of animals with DVE-1::GFP in cytosol.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41792-fig3-v2.tif"/></fig><p>We also tested the subcellular localization of DVE-1 K327R under <italic>ulp-4</italic> RNAi. Different from wild type proteins, DVE-1 K327R constitutively localized in the nucleus of <italic>C. elegans</italic>, even if <italic>ulp-4</italic> was knocked down by RNAi (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Conversely, SUMO-mimetic DVE-1 constitutively localized in the cytosol (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). Taken together, during mitochondrial stress, ULP-4 deSUMOylates DVE-1 at K327 residue to allow its nuclear accumulation to initiate UPR<sup>mt</sup>.</p></sec><sec id="s2-4"><title>ULP-4 deSUMOylates ATFS-1 at K326 residue upon mitochondrial stress</title><p>Aside from DVE-1, we found that a fragment of ATFS-1 (372–472), another transcription factor in UPR<sup>mt</sup>, was also able to interact with ULP-4 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, note: expression of full-length ATFS-1 is toxic in yeast). Similar as DVE-1, ATFS-1 could only interact with ULP-4, but not ULP-2 and ULP-5 (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Four lysine residues were predicted by GPS-SUMO tool to be potential SUMOylation sites in ATFS-1 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>) (<xref ref-type="bibr" rid="bib45">Zhao et al., 2014</xref>). In vivo SUMOylation assay in 293 T cells identified K326 residue as the <italic>bona fide</italic> ATFS-1 SUMOylation site (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). SUMOylation of ATFS-1 was also observed in <italic>C. elegans</italic>, which could be abolished by mutating K326 residue to arginine (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Expression of ULP-4 C48, the catalytic domain of ULP-4, in 293 T cells deSUMOylated ATFS-1 (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Lastly, expression of ATFS-1 K326R in <italic>atfs-1(tm4525)</italic> hypomorphic allele bypassed the requirement of <italic>ulp-4</italic> in UPR<sup>mt</sup> activation (<xref ref-type="fig" rid="fig4">Figure 4G</xref>).</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.41792.010</object-id><label>Figure 4.</label><caption><title>ULP-4 deSUMOylates ATFS-1 at K326 residue upon mitochondrial stress.</title><p>(<bold>A</bold>) Yeast two-hybrid assay for ATFS-1 and ULP-4 interaction. ATFS-1 was truncated into 33–174, 175-371and 372–472 fragments. (<bold>B</bold>) Yeast two-hybrid assay for ATFS-1 372–472 and ULPs. (<bold>C</bold>) Predicted SUMOylation sites of ATFS-1 using GPS-SUMO web service. (<bold>D</bold>) In vivo SUMOylation assay for ATFS-1. Myc-tagged wild-type ATFS-1<sup>Δ1-32</sup> or ATFS-1<sup>Δ 1-32</sup> lysine mutants, SMO-1 and E2 SUMO conjugating enzyme UBC9 were expressed in 293 T cells. (<bold>E</bold>) ATFS-1 SUMOylation in worms. Wild-type or ATFS-1<sup>Δ 1-184</sup> K326R was expressed in worms. (<bold>F</bold>) ATFS-1 <sup>Δ 1-32</sup> deSUMOylation in 293 T cells. SMO-1, UBC9, ATFS-1 <sup>Δ 1-32</sup> and ULP-4 C48 domain were expressed in 293 T cells. (<bold>G</bold>) Representative fluorescent images of <italic>atfs-1(tm4525); hsp-60p::gfp</italic> with wild-type ATFS-1 or ATFS-1 K326R animals fed on control or <italic>ulp-4</italic> RNAi.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41792-fig4-v2.tif"/></fig></sec><sec id="s2-5"><title>SUMOylation affects the stability and transcriptional activity of ATFS-1</title><p>To see if SUMO also affects ATFS-1 localization, we used <italic>hsp-16.2</italic> heat shock promoter to drive the expression of GFP-tagged full-length ATFS-1. Upon mitochondrial perturbation, ATFS-1 was still able to translocate to the nucleus when ULP-4 expression is diminished (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). It should be noted that it is very difficult to express full-length ATFS-1 in worms, probably due to toxicity (expression of full-length ATFS-1 in yeast is lethal). Therefore, we made truncations of ATFS-1, and found that ATFS-1<sup>Δ1-184</sup> expressed well and localized in the nucleus (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). Abolishing SUMOylation site of ATFS-1 (K326R) did not affect subcellular localization of ATFS-1 <sup>Δ 1-184</sup> either (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>).</p><fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.41792.011</object-id><label>Figure 5.</label><caption><title>SUMOylation affects the stability and transcriptional activity of ATFS-1.</title><p>(<bold>A</bold>) Representative fluorescent images of ATFS-1::GFP localization with indicated treatment. (<bold>B</bold>) Representative fluorescent images of ATFS-1 <sup>Δ 1-184</sup>::GFP. Worms were heat-shocked at 37°C for 1 hr and photographed at indicated time points. (<bold>C</bold>) Immunoblot of ATFS-1::GFP expression in <italic>atfs-1p::atfs-1::gfp</italic> worms fed with indicated RNAi. (<bold>D</bold>) Representative fluorescent images of wild-type, SUMOylation mutant or SUMOylation mimetic ATFS-1 <sup>Δ 1-184</sup>::GFP with indicated RNAi. (<bold>E</bold>) Statistic result of (<bold>D</bold>). (<bold>F</bold>) Diagram of transcriptional activity assay. ATFS-1 <sup>Δ 1-32</sup> was cloned into a vector containing Gal4-BD at N-terminus to induce luciferase expression. (<bold>G</bold>) Transcriptional activity assay of ATFS-1 <sup>Δ 1-32</sup>, ATFS-1 <sup>Δ 1-32</sup> K326R or SMO-1-ATFS-1 <sup>Δ 1-32</sup>. Student’s t-test. ***p&lt;0.0002. Error bars indicate standard deviation. (<bold>H</bold>) Quantitative PCR of <italic>god-2</italic> and <italic>gst-14</italic> mRNA levels in wild-type or <italic>atfs-1</italic> K326R worms fed with indicated RNAi. .</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41792-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41792.012</object-id><label>Figure 5—figure supplement 1.</label><caption><title>SUMOylation affects the stability and transcriptional activity of ATFS-1.</title><p>(<bold>A</bold>) Representative fluorescent images showing expression level of full-length ATFS-1, ATFS-1<sup>Δ 1-32</sup>, and ATFS-1<sup>Δ 1-184</sup>. (<bold>B</bold>) Representative fluorescent images showing subcellular localization of ATFS-1<sup>Δ 1-184</sup> K326R. (<bold>C</bold>) <italic>ulp-4</italic> RNAi resulted in ATFS-1 degradation, which was partially prevented by treating with protease inhibitor MG132. (<bold>D</bold>) Immunoblot of wild-type, K326R or SMO-1-conjugated ATFS-1 ATFS-1<sup>Δ1-32</sup> in 293 T cells. GFP was co-transfected as a control of transfection efficiency.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41792-fig5-figsupp1-v2.tif"/></fig></fig-group><p>Interestingly, we noticed that <italic>ulp-4</italic> RNAi greatly reduced the protein level of ATFS-1<sup>Δ 1-184</sup> (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>), suggesting that <italic>ulp-4</italic> RNAi may affect ATFS-1 expression, or stability. Seven hours after heat induction of ATFS-1 expression, levels of ATFS-1<sup>Δ 1-184</sup> were comparable in control or <italic>ulp-4</italic> RNAi animals (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). However, after 24 hours, ATFS-1<sup>Δ 1-184</sup> level in <italic>ulp-4</italic> RNAi treated animals significantly decreased (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Treating worms with proteasome inhibitor MG132 partially rescued the reduction of ATFS-1 <sup>Δ 1-184</sup> under <italic>ulp-4</italic> RNAi (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>), suggesting that <italic>ulp-4</italic> RNAi affects ATFS-1 protein stability. Full-length ATFS-1 proteins could be detected when mitochondrial protease LON-1 was inhibited (<xref ref-type="bibr" rid="bib26">Nargund et al., 2012</xref>). Treating worms with <italic>lon-1</italic> RNAi, we showed that full-length ATFS-1 levels were also reduced under <italic>ulp-4</italic> RNAi (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Mutation (K326R) that abolished ATFS-1 SUMOylation partially restored its protein level under <italic>ulp-4</italic> RNAi (<xref ref-type="fig" rid="fig5">Figure 5D–E</xref>). In contrary, fusion of SMO-1 to mimic SUMOylated form of ATFS-1 significantly reduced its protein level (<xref ref-type="fig" rid="fig5">Figure 5D–E</xref>). Taken together, these results suggest that SUMOylation reduces the stability of ATFS-1.</p><p>It has been shown that ATFS-1<sup>Δ1-32</sup>, with impaired mitochondrial targeting sequence, could be expressed in the nucleus of HeLa cells (<xref ref-type="bibr" rid="bib26">Nargund et al., 2012</xref>). Therefore, it might be possible to directly test the transcriptional activity of ATFS-1<sup>Δ1-32</sup> in mammalian system. We employed a luciferase reporter assay, in which transcription factor of interest (e.g. wild type ATFS-1<sup>Δ1-32</sup>, ATFS-1<sup>Δ1-32</sup> K326R or SMO-1-ATFS-1<sup>Δ1-32</sup>) is fused with Gal4 binding domain (BD) to drive the expression of luciferase (<xref ref-type="fig" rid="fig5">Figure 5F</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). We found that mutation of ATFS-1 SUMOylation site greatly enhanced its transcriptional activity, whereas SUMO-mimetic significantly impaired the activity (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). Lastly, transcriptions of genes known to be driven by ATFS-1 (eg. <italic>gpd-2</italic> and <italic>gst-14</italic>) (<xref ref-type="bibr" rid="bib26">Nargund et al., 2012</xref>; <xref ref-type="bibr" rid="bib27">Nargund et al., 2015</xref>) were blocked by <italic>ulp-4</italic> RNAi, which could be partially rescued with ATFS-1 K326R mutation (<xref ref-type="fig" rid="fig5">Figure 5H</xref>). Thus, SUMOylation also impairs the transcriptional activity of ATFS-1.</p></sec><sec id="s2-6"><title><italic>ulp-4</italic> is essential for UPR<sup>mt</sup>-regulated innate immunity and lifespan extension</title><p>During mitochondrial stress, UPR<sup>mt</sup> not only initiates mitochondrial protective responses, but also activates immune responses and extends worm lifespan (<xref ref-type="bibr" rid="bib21">Liu et al., 2014</xref>; <xref ref-type="bibr" rid="bib23">Merkwirth et al., 2016</xref>; <xref ref-type="bibr" rid="bib30">Pellegrino et al., 2014</xref>; <xref ref-type="bibr" rid="bib39">Tian et al., 2016</xref>). The essential function of <italic>ulp-4</italic> in signaling UPR<sup>mt</sup> makes it likely to be crucial for animal fitness during mitochondrial stress. Indeed, worms treated with <italic>cco-1</italic> RNAi had a severe synthetic growth defect on <italic>ulp-4</italic> RNAi (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Consistently, <italic>ulp-4(tm1597)</italic> mutants revealed a more severe developmental delay when grown on <italic>spg-7</italic> RNAi (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A–B</xref>). Mutation of the SUMOylation sites of ATFS-1 and DVE-1 in <italic>C. elegans</italic> partially rescued the developmental delay of <italic>spg-7</italic> mutants (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C–E</xref>). The survival rate of worms exposed to high dosage of antimycin was also significantly reduced in <italic>ulp-4</italic> RNAi (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1F–G</xref>).</p><fig-group><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.41792.013</object-id><label>Figure 6.</label><caption><title><italic>ulp-4</italic> is essential for UPR<sup>mt</sup>-regulated innate immunity and lifespan extension.</title><p>(<bold>A</bold>) Representative images of wild-type worms raised on indicated RNAi. <italic>cco-1</italic> RNAi was treated 16 hr later after control or <italic>ulp-4</italic> RNAi. (<bold>B</bold>) Representative fluorescent images of <italic>hsp-6p::gfp</italic> worms. Animals were pre-treated with control or <italic>ulp-4</italic> RNAi for 24 hr, and then fed with <italic>P. aeruginosa</italic> for additional 48 hr. Student’s t-test. Error bars indicate standard deviation. **p&lt;0.002 and ***p&lt;0.0002. (<bold>C</bold>) Fold changes of immune response gene <italic>lys-2</italic>, <italic>zip-2, clec-4, clec-65</italic> and <italic>ugt-61</italic> mRNA levels in control or <italic>ulp-4</italic> RNAi animals after exposure to <italic>P. aeruginosa</italic>. (<bold>D</bold>) Immune response reporter strain <italic>irg-1p::gfp</italic> fed with control or <italic>ulp-4</italic> RNAi was infected with <italic>P. aeruginosa</italic> strain PA14. (<bold>E</bold>) Representative images of wild-type worms fed with control or <italic>ulp-4</italic> RNAi for 24 hr and then exposed to <italic>P. aeruginosa</italic>. (<bold>F</bold>) PA14 survival assay in wild-type, <italic>ulp-4</italic> knockdown or overexpression animals. N = 3 biological replicates, n &gt; 40 worms per replicate. Analyzed using Log-Rank method and p&lt;0.05 (N2 control RNAi vs N2 <italic>ulp-4</italic> RNAi). (<bold>G</bold>) PA14 survival assay in N2 or <italic>atfs-1</italic> K326R; <italic>dve-1</italic> K327R animals with indicated RNAi. N = 2 biological replicates, n &gt; 35 worms per replicate. Analyzed using Log-Rank method, p&lt;0.05 (N2 control RNAi vs N2 <italic>ulp-4</italic> RNAi), p&gt;0.05(<italic>atfs-1</italic> K326R; <italic>dve-1</italic> K327R control RNAi vs <italic>atfs-1</italic> K326R; <italic>dve-1</italic> K327R <italic>ulp-4</italic> RNAi). (<bold>H</bold>) Representative lifespan result of N2 or <italic>atfs-1</italic> K326R; <italic>dve-1</italic> K327R animals fed with indicated RNAi. n &gt; 80 worms per condition. Analyzed using Log-Rank method, p&lt;0.0001 (N2 control +<italic>cco-1</italic> RNAi vs N2 <italic>ulp-4</italic> RNAi + <italic>cco-1</italic> RNAi), p&lt;0.01(N2 <italic>ulp-4 +cco-1</italic> RNAi vs <italic>atfs-1</italic> K326R; <italic>dve-1</italic> K327R <italic>ulp-4 +cco-1</italic> RNAi).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41792-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41792.014</object-id><label>Figure 6—figure supplement 1.</label><caption><title><italic>ulp-4</italic> is essential for UPR<sup>mt</sup>-regulated innate immunity and lifespan extension.</title><p>(<bold>A,B</bold>) Representative images (<bold>A</bold>) and statistical results of worm lengths (<bold>B</bold>) for wild-type or <italic>ulp-4(tm1597)</italic> fed with control or <italic>spg-7</italic> RNAi, n &gt; 15 worms. (<bold>C–E</bold>) Representative images (<bold>C,D</bold>) and statistical results of worm lengths (<bold>E</bold>) for worms with indicated genotype and RNAi treatment, n &gt; 15 worms. (<bold>F,G</bold>) Representative images (<bold>F</bold>) and statistical results of survival rates for control or <italic>ulp-4</italic> RNAi animals treated with high dosage of antimcyin (20 µg antimycin in a 6-well plate), N = 3 biological replicates, n &gt; 40 worms per replicate. (<bold>H–J</bold>) Lifespan of worms with indicated genotype and RNAi treatment. Analyzed using Log-Rank method (n &gt; 60 worms). (<bold>H</bold>) p=0.2254 (N2 +control RNAi vs ULP-4 OE +control RNAi), p=0.6672 (N2 +<italic>cco-1</italic> RNAi vs ULP-4 OE +<italic>cco-1</italic> RNAi). (<bold>I</bold>) p&lt;0.0001 (N2 +control RNAi vs N2 +<italic>smo-1</italic> RNAi), p=0.0006 (<italic>spg-7</italic> +control RNAi vs <italic>spg-7 +smo-1</italic> RNAi) (<bold>J</bold>) p&lt;0.0001 (<italic>spg-7</italic> vs <italic>spg-7</italic>; ATFS-1 K326R), p=0.0047 (<italic>spg-7</italic> vs <italic>spg-7</italic>; DVE-1 K327R) and p&lt;0.0001 (<italic>spg-7</italic> vs <italic>spg-7</italic>; ATFS-1 K326R; DVE-1 K327R). Student’s t-test. Error bars indicate standard deviation. ns not significant, *p&lt;0.05 and ***p&lt;0.0002.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41792-fig6-figsupp1-v2.tif"/></fig></fig-group><p>A broad range of microbes isolated from natural habitats harboring wild <italic>C. elegans</italic> populations could perturb mitochondrial function and induce the expression of <italic>hsp-6p::gfp</italic> (<xref ref-type="bibr" rid="bib21">Liu et al., 2014</xref>). <italic>ulp-4</italic> RNAi also impaired UPR<sup>mt</sup> activation when we challenged worms with a <italic>Pseudomonas</italic> strain, a mitochondrial insult isolated from the natural habitat of <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib21">Liu et al., 2014</xref>) (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Moreover, <italic>ulp-4</italic> RNAi suppressed the activation of immune response and xenobiotic detoxification response (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). To further validate the requirement of <italic>ulp-4</italic> in UPR<sup>mt</sup>-mediated immune response, we treated <italic>irg-1p::gfp</italic> transgenic worms, a reporter strain for pathogen-infected response (<xref ref-type="bibr" rid="bib8">Estes et al., 2010</xref>), with control or <italic>ulp-4</italic> RNAi and then challenged them with <italic>Pseudomonas</italic>. We showed that deficiency of <italic>ulp-4</italic> greatly suppressed the induction of <italic>irg-1</italic> (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Deficiency of <italic>ulp-4</italic> also impaired worm development and survival rate when they were infected with <italic>Pseudomonas</italic> (<xref ref-type="fig" rid="fig6">Figure 6E–F</xref>) (<xref ref-type="bibr" rid="bib18">Kirienko et al., 2014</xref>). The reduced survival rate of <italic>ulp-4</italic>-deficient worms could be rescued with <italic>atfs-1</italic> K326R; <italic>dve-1</italic> K327R mutations, further demonstrating that deSUMOylation of ATFS-1 and DVE-1 is the major function of ULP-4 during mitochondrial stress (<xref ref-type="fig" rid="fig6">Figure 6G</xref>).</p><p>Finally, we analyzed the lifespans of control or <italic>ulp-4</italic> RNAi worms. Under unstressed condition, <italic>ulp-4</italic> RNAi did not affect worm lifespan. However, <italic>ulp-4</italic> RNAi greatly suppressed the lifespan extension in <italic>cco-1</italic> RNAi-treated worms, which could be rescued by mutations of SUMOylation site within ATFS-1 and DVE-1 (<xref ref-type="fig" rid="fig6">Figure 6H</xref>). Overexpression of <italic>ulp-4</italic> neither affects the basal level of UPR<sup>mt</sup> under unstressed condition (<xref ref-type="fig" rid="fig1">Figure 1G</xref>), nor affects worm lifespans with or without mitochondrial stress (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1H</xref>). In contrary, <italic>smo-1</italic> RNAi shortened worm lifespan, but greatly extended the lifespan of <italic>spg-7</italic> mutants (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1I</xref>). Mutations of SUMOylation site within ATFS-1 and DVE-1 extended lifespan of <italic>spg-7</italic> mutants as well (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1J</xref>). Taken together, these results suggest that <italic>ulp-4</italic> is required for mitochondrial stress-induced lifespan extension.</p><p>In summary, our studies indicate that mitochondrial stress signals through ULP-4, which deSUMOylates DVE-1 and ATFS-1 to modulate their localization, stability and transcriptional activity. Consequences of these events are elevated innate immunity and prolonged lifespan (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.41792.015</object-id><label>Figure 7.</label><caption><title>Model for ULP-4-mediated UPR<sup>mt</sup>﻿ signaling.</title><p>(<bold>A</bold>) Under normal condition, ATFS-1 is imported into mitochondria and degraded by mitochondrial protease. DVE-1 is mainly localized in the cytosol. No UPR<sup>mt</sup> is induced. The animal is normal lived and with normal innate immunity. (<bold>B</bold>) Upon mitochondrial stress, DVE-1 is deSUMOylated by ULP-4 and translocated to the nucleus. Mitochondrial importer efficiency is compromised, leading to ATFS-1 nuclear accumulation. ULP-4 deSUMOylates ATFS-1, leading to increased stability and transcriptional activity (active form). UPR<sup>mt</sup> is induced. Animals are long-lived, with increased innate immunity. (<bold>C</bold>) Reduction of ULP-4 activity during mitochondrial stress results in SUMOylation of DVE-1 and ATFS-1. SUMOylated of DVE-1 localizes in the cytosol; whereas SUMOylated ATFS-1, which has lower transcriptional activity, is prone to degradation. Induction of UPR<sup>mt</sup> is impaired. UPR<sup>mt</sup>-regulated innate immunity and lifespan extension is partially suppressed.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41792-fig7-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We have identified a SUMO-specific peptidase ULP-4 that participates in <italic>C. elegans</italic> UPR<sup>mt</sup>. ULP-4 regulates the entire transcriptional program of UPR<sup>mt</sup>, underscoring the importance of ULP-4-mediated deSUMOylation in UPR<sup>mt</sup> signaling. However, how mitochondrial stress signals to ULP-4 warrants future analysis.</p><p>SUMOylation affects protein function through several mechanisms, including changes of protein conformation, protein–protein interaction, protein stability and subcellular localization (<xref ref-type="bibr" rid="bib4">Chymkowitch et al., 2015</xref>). Interestingly, we find that SUMOylation affects DVE-1 and ATFS-1 through two distinct mechanisms: change of DVE-1 subcellular localization vs. changes of ATFS-1 stability and transcriptional activity. DVE-1 and ATFS-1 constitute the two axes in the transcriptional program of UPR<sup>mt</sup>, each might regulate a different subset of downstream genes. For instance, ATFS-1 has been shown to be the primary factor that controls the expression of genes involved in mitochondrial protein folding, glycolysis, xenobiotic detoxification and immune response (<xref ref-type="bibr" rid="bib26">Nargund et al., 2012</xref>; <xref ref-type="bibr" rid="bib30">Pellegrino et al., 2014</xref>). A detailed analysis of DVE-1 and ATFS-1 substrate selection may facilitate the understanding of why cells employ such intricate regulation of transcriptional response during mitochondrial stress.</p><p>DVE-1 is homologous to mammalian SATB class of proteins that function in chromatin remodeling and transcription. Interestingly, it is reported that SATB1 and SATB2 could also be SUMOylated. For example, SUMOylation of SATB2 targets it to the nuclear periphery, where it regulates immunoglobulin μ gene expression (<xref ref-type="bibr" rid="bib6">Dobreva et al., 2003</xref>). SUMOylation of SATB1 targets it to the promyelocytic leukemia (PML) nuclear bodies where it undergoes caspase-mediated cleavage (<xref ref-type="bibr" rid="bib38">Tan et al., 2008</xref>). SATB1 has also been shown to form a ‘cage’-like distribution and anchors specialized DNA sequences onto its network (<xref ref-type="bibr" rid="bib3">Cai et al., 2003</xref>). Histone H3K9 and H3K14 acetylation mark the binding sites of SATB1, whereas in SATB1 deficient cells, these sites are marked by H3K9 methylation (<xref ref-type="bibr" rid="bib3">Cai et al., 2003</xref>). Similarly, studies in <italic>C. elegans</italic> reported that during mitochondrial perturbation, H3K9 di-methylation globally marks chromatin, leaving portions of chromatin open-up where binding of DVE-1 occurs (<xref ref-type="bibr" rid="bib39">Tian et al., 2016</xref>). All these findings point to the conserved function and regulatory mechanisms of DVE-1 and SATB1. Therefore, it will be interesting in the future to directly test if SATB1 functions as mammalian DVE-1 to signal UPR<sup>mt</sup>. Furthermore, ATF5 has been reported to constitute mammalian homolog of ATFS-1 (<xref ref-type="bibr" rid="bib9">Fiorese et al., 2016</xref>). It will also be interesting to see if SUMOylation can affect the stability and activity of ATF5.</p><p>Several mitochondrial quality control processes have evolved to maintain and restore proper mitochondrial function, including mitochondrial unfolded protein response (UPR<sup>mt</sup>), mitochondrial dynamics, and mitophagy (<xref ref-type="bibr" rid="bib1">Andreux et al., 2013</xref>). Cells selectively activate each quality control pathway, depending on the stress level of mitochondria (<xref ref-type="bibr" rid="bib1">Andreux et al., 2013</xref>; <xref ref-type="bibr" rid="bib29">Pellegrino et al., 2013</xref>). Mild mitochondrial inhibition is often associated with the activation of UPR<sup>mt</sup> to maintain and restore proteostasis. As stress exceeds the protective capacity of UPR<sup>mt</sup>, cells may employ mitochondrial fusion to dilute damaged materials, and activate mitochondrial fission to isolate severely damaged mitochondria for removal through mitophagy. Drp1, the central protein that controls mitochondrial fission, could be SUMOylated (<xref ref-type="bibr" rid="bib31">Prudent et al., 2015</xref>). A RING-finger containing protein MAPL functions as the E3 ligase to promote Drp1 SUMOylation on the mitochondria. SUMOylated Drp1 facilitates cristae remodeling, calcium flux and release of cytochrome c, and stabilizes ER/mitochondrial contact sites. Whether SUMOylation affects other proteins in the mitochondrial quality control processes, such as those govern mitophagy, are worth to explore. The discovery of SUMOylation in modulating UPR<sup>mt</sup> opens up a new research direction to study post-translational regulation of UPR<sup>mt</sup>, and UPR<sup>mt</sup>-mediated immunity and longevity.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td valign="bottom"><italic>hsp-6p</italic>::gfp</td><td valign="bottom">Caenorhabditis <break/>Genetics Center</td><td>WB Strain: SJ4100</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td valign="bottom"><italic>hsp-16.2p</italic>::gfp</td><td valign="bottom">Caenorhabditis <break/>Genetics Center</td><td>WB Strain: CL2070</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td valign="bottom"><italic>hsp-4p</italic>::gfp</td><td valign="bottom">Caenorhabditis <break/>Genetics Center</td><td>WB Strain: SJ4005</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td valign="bottom"><italic>dve-1p::dve-1::gfp</italic></td><td valign="bottom">Caenorhabditis <break/>Genetics Center</td><td>WB Strain: SJ4198</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td valign="bottom"><italic>hsp-60p::gfp</italic></td><td valign="bottom">Caenorhabditis <break/>Genetics Center</td><td>WB Strain: SJ4058</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td valign="bottom">N2</td><td valign="bottom">Caenorhabditis <break/>Genetics Center</td><td>WB Strain: N2</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td valign="bottom">DA2249 (<italic>spg-7</italic> mutant)</td><td valign="bottom">Caenorhabditis <break/>Genetics Center</td><td valign="bottom">WB Strain: DA2249</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td valign="bottom"><italic>tm1597</italic> (<italic>ulp-4</italic> mutant)</td><td valign="bottom">National <break/>Bioresource Project</td><td>WB Variation: <italic>tm1597</italic></td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td valign="bottom"><italic>hsp-60p::gfp; atfs-1</italic> <break/>(<italic>tm4525</italic>)</td><td valign="bottom">PMID:22700657</td><td>Dr. Cole Haynes <break/>(University of <break/>Massachusetts Medical <break/>School)</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>hsp-60p::gfp; tm1597</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>dve-1p::dve-1 K327R::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>hsp-16.2p::dve-1::smo-</italic> <break/><italic>1::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>hsp-16.2p::atfs-1::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>hsp-16.2p::atfs-1Δ1–32::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>hsp-16.2p::atfs-1Δ1–</italic> <break/><italic>184::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>hsp-16.2p::atfs-1Δ1–</italic> <break/><italic>184::smo-1::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>hsp-16.2p::atfs-1Δ1–184</italic> <break/><italic>K326R::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>hsp-60p::gfp;atfs-1(tm4525);atfs-1p::atfs-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>hsp-60p::gfp;atfs-1(tm4525);atfs-1p::atfs-1 K326R</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>dve-1 K327R</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom">Cas9 mutation</td></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>atfs-1 K326R</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom">Cas9 mutation</td></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>atfs-1 K326R dve-1 K327R</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom">Cas9 mutation</td></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>dve-1 K327R;hsp-6p::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom">Cas9 mutation</td></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>rpl-28p::ulp-4(opti)::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Genetic <break/>reagent <break/>(<italic>C. elegans</italic>)</td><td><italic>rpl-28p::ulp-4(opti)::gfp;</italic> <break/><italic>dve-1p::dve-1::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td valign="bottom">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td><italic>293T</italic></td><td valign="bottom">ATCC</td><td valign="bottom">CRL-3216</td><td valign="bottom"/></tr><tr><td>Antibody</td><td>Mouse monoclonal <break/>anti-GFP</td><td>sungen biotech</td><td>CAT#KM8009</td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Rabbit <break/>polyclonal <break/>anti-GFP</td><td>abcam</td><td>CAT#ab290</td><td valign="bottom">(1:1000)</td></tr><tr><td>Antibody</td><td>Rabbit <break/>polyclonal <break/>anti-ATFS-1</td><td>abclonal</td><td>N/A</td><td valign="bottom">custom <break/>made (1:5000)</td></tr><tr><td>Antibody</td><td>Rabbit <break/>polyclonal <break/>anti-DVE-1</td><td>abclonal</td><td>N/A</td><td valign="bottom">custom <break/>made (1:5000)</td></tr><tr><td>Antibody</td><td>Rabbit <break/>polyclonal <break/>anti-SMO-1</td><td>abclonal</td><td>N/A</td><td valign="bottom">custom <break/>made (1:5000)</td></tr><tr><td>Antibody</td><td>Mouse <break/>monoclonal <break/>anti-MYC</td><td>CST</td><td>CAT#2276</td><td valign="bottom">(1:1000)</td></tr><tr><td>Antibody</td><td>Rat <break/>monoclonal <break/>anti-TUBULIN</td><td>abcam</td><td>CAT#6161</td><td valign="bottom">(1:1000)</td></tr><tr><td>Antibody</td><td>Rabbit <break/>monoclonal <break/>anti-UBC9</td><td>abcam</td><td>CAT#ab75854</td><td valign="bottom">(1:1000)</td></tr><tr><td>Strain <break/>(<italic>Pseudomonas</italic> <break/><italic>aeruginosa</italic>)</td><td valign="bottom">Pseudomonas <break/>aeruginosa</td><td valign="bottom">PMID:24695221</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Strain <break/>(<italic>Pseudomonas</italic> <break/><italic>aeruginosa</italic>)</td><td valign="bottom">Pseudomonas <break/>aeruginosa</td><td>PMID:25274306</td><td valign="bottom">WB Strain: PA14</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>-Trp DO suplement</td><td valign="bottom">Coolaber</td><td>CAT#PM2140</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>-Leu -Trp DO <break/>suplement</td><td>Clontech</td><td>CAT#630417</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>-Leu -Trp -His DO <break/>suplement</td><td valign="bottom">Clontech</td><td>CAT#630419</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>-Leu -Trp -His -Ade <break/>DO suplement</td><td valign="bottom">Clontech</td><td>CAT#630428</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>-Leu -Trp -His -Met <break/>DO suplement</td><td valign="bottom">Coolaber</td><td>CAT#PM2250</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>Minimal SD Base</td><td valign="bottom">Clontech</td><td>CAT#630411</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>SYBR Green QPCR mix</td><td valign="bottom">Biorad</td><td>CAT#172–5122</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>transcript one-step <break/>gDNA removal and <break/>cDNA synthesis supermix</td><td valign="bottom">Transgene</td><td>AT311-03</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>Triton X-100</td><td valign="bottom">sigma</td><td>T9284</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>Trizol</td><td valign="bottom">Cwbio</td><td>CW0580A</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>Lipofectamine 3000</td><td valign="bottom">life</td><td>L3000015</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>Yeast Plasmid <break/>Extraction Kit</td><td valign="bottom">solarbio</td><td>D1160-100</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>dynabeads <break/>protei G</td><td valign="bottom">life</td><td>10004D</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>Protease Inhibitor <break/>Cocktail</td><td valign="bottom">bimake</td><td>B14002</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>Antimycin</td><td valign="bottom">sigma</td><td>A8674</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>N-Ethylmaleimide</td><td valign="bottom">J and K</td><td>128-53-0</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>5-FLUORO-2'- <break/>DEOXYURIDINE</td><td valign="bottom">sigma</td><td>F0503</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>ECL western <break/>blotting kit</td><td>Pierce</td><td>CAT#32106</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>Dual-Luciferase <break/>Reporter Assay <break/>Systerm</td><td>Promega</td><td>CAT#E1910</td><td valign="bottom"/></tr><tr><td>Commercial <break/>assay or kit</td><td>Matchmaker GAL4 <break/>Two-Hybrid System 3</td><td>Clontech</td><td>CAT# PT3247-1</td><td valign="bottom"/></tr><tr><td>Software, <break/>algorithm</td><td>Graph Pad Prism <break/>Software</td><td valign="bottom">GraphPad <break/>Software</td><td><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/scientific-software/prism/">https://www.graphpad.com/scientific-software/prism/</ext-link></td><td valign="bottom"/></tr><tr><td>Software, <break/>algorithm</td><td>MAFFT</td><td>PMID:23329690</td><td><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/Tools/msa/mafft/">https://www.ebi.ac.uk/Tools/msa/mafft/</ext-link></td><td valign="bottom"/></tr><tr><td>Software, <break/>algorithm</td><td>SMART</td><td valign="bottom">PMID: 29040681</td><td><ext-link ext-link-type="uri" xlink:href="http://smart.embl-heidelberg.de">http://smart.embl-heidelberg.de</ext-link></td><td valign="bottom"/></tr><tr><td>Software, <break/>algorithm</td><td>ImageJ</td><td>PMID: 22930834</td><td><ext-link ext-link-type="uri" xlink:href="https://imagej.net/Downloads">https://imagej.net/Downloads</ext-link></td><td valign="bottom"/></tr><tr><td>Software, <break/>algorithm</td><td>SUMO-GPS</td><td valign="bottom">PMID: 24880689</td><td><ext-link ext-link-type="uri" xlink:href="http://sumosp.biocuckoo.org">http://sumosp.biocuckoo.org</ext-link></td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>CMVp-</italic>myc<italic>-dve-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>CMVp-</italic>myc<italic>-dve-1</italic> <break/><italic>K327R</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>CMVp-</italic>myc<italic>-33–472</italic> <break/><italic>atfs-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>CMVp-</italic>myc<italic>-33–472</italic> <break/><italic>atfs-1 K326R</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>CMVp-</italic>gfp<italic>-smo-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>CMVp-ubc9</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>CMVp-ulp-4 C48</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 BD-dve-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 BD-dve-1</italic> <break/><italic>K327R</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 BD-dve-1</italic> <break/><italic>K461R</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 BD-dve-1</italic> <break/><italic>K465R</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 BD-dve-1</italic> <break/><italic>K327R K355R</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 BD-ulp-4</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 BD-smo-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 BD-smo-1</italic> <break/><italic>delta GG</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-smo-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-smo-1</italic> <break/><italic>delta GG</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-smo-1 GG'</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-33–184</italic> <break/><italic>atfs-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-185–371</italic> <break/><italic>atfs-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-372–472</italic> <break/><italic>atfs-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-dve-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-1–150</italic> <break/><italic>dve-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-151–300</italic> <break/><italic>dve-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-301–468</italic> <break/><italic>dve-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-ulp-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-ulp-2</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-ulp-4</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 AD-ulp-5</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 BD-dve-1</italic> <break/><italic>met17p-ulp-4</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 BD-dve-1</italic> <break/><italic>met17p-ulp-5</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>adh1p-gal4 BD-dve-1</italic> <break/><italic>in pBridge</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>Adh1p-gal4 AD-33–184</italic> <break/><italic>atfs-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>Adh1p-gal4 AD-185–371</italic> <break/><italic>atfs-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>Adh1p-gal4 AD-372–472</italic> <break/><italic>atfs-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>CMVp-gal4 BD-33–472</italic> <break/><italic>atfs-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>CMVp-gal4 BD-33–472</italic> <break/><italic>atfs-1 K327R</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>CMVp-gal4 BD-smo-</italic> <break/><italic>1-33-472 atfs-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>rpl-28p::ulp-4(opti)::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>hsp-16.2p::atfs-1::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>hsp-16.2p::33–472</italic> <break/><italic>atfs-1::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>hsp-16.2p::185–472</italic> <break/><italic>atfs-1::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>hsp-16.2p::185–472</italic> <break/><italic>atfs-1 K326R::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>atfs-1p::atfs-1</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>atfs-1p::atfs-1 K326R</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>dve-1p::dve-1 K327R::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>hsp-16.2p::smo-1::dve-1::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>hsp-16.2p::dve-1::smo-1::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr><tr><td>Recombinant <break/>DNA reagent</td><td><italic>hsp-16.2p::atfs-1::smo-1::gfp</italic></td><td valign="bottom">This paper</td><td>N/A</td><td valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Worm strains</title><p>SJ4100 (zcIs13[<italic>hsp-6p::gfp</italic>]), CL2070 (dvIs70[<italic>hsp-16.2p::gfp</italic>]), SJ4005 (zcIs4[<italic>hsp-4p::gfp</italic>]), SJ4058 (zcls9[hsp-60p::gfp]), SJ4198 (zcls39[<italic>dve-1p::dve-1::gfp</italic>]), <italic>ulp-4(tm1597)</italic>, <italic>spg-7(ad2249)</italic> and N2 wild-type worms were obtained from Caenorhabditis Genetics Center. <italic>hsp-60p::gfp;atfs-1</italic>(tm4525) is a generous gift from Dr. Cole Haynes. <italic>dve-1p::dve-1::gfp</italic> plasmid is a gift from Dr. Cole Haynes. We used site-direct mutagenesis to generate <italic>dve-1p::dve-1 K327R::gfp</italic> plasmid and micro-injected into worms.</p><p>For generation of <italic>hsp-16.2p::dve-1::smo-1::gfp</italic> worms, <italic>hsp-16.2</italic> promoter, <italic>dve-1::smo-1</italic> and <italic>gfp</italic> sequences were sub-cloned into pDD49.26 vector. Three glycine residues were placed as linker between <italic>smo-1</italic> and <italic>dve-1</italic>.</p></sec><sec id="s4-2"><title>Cell line</title><p>HEK293T cell was obtained from ATCC, which was authenticated by ATCC. Cells were validated to be free of mycoplasma contamination. No commonly misidentified cell lines were used.</p></sec><sec id="s4-3"><title><italic>C. elegans</italic>, yeast and cell culture</title><p><italic>C. elegans</italic> were cultured at 20°C and fed with <italic>E.coli</italic> OP50 on Nematode Growth Media unless otherwise indicated. Yeast strain AH109 for yeast two-hybrid and three-hybrid assays was cultured with YPDA media at 30°C unless otherwise indicated. 293 T cells were cultured with DMEM (10% fetal bovine serum) at 37°C.</p></sec><sec id="s4-4"><title>Induction of UPR<sup>mt</sup></title><p>For RNAi-induced UPR<sup>mt</sup>, RNAi bacteria were grown in LB containing 50 µg/ml carbenicillin at 37°C overnight. 200 µl of RNAi bacteria was seeded onto 6 cm worm plates with 5 mM IPTG. Dried plates were kept at room temperature overnight to allow IPTG induction of dsRNA expression. Synchronized L1 worms were raised on the RNAi plates at 20°C. After 24 hr, 200 µl 10X concentrated RNAi (<italic>atp-2</italic>, <italic>cco-1</italic> or <italic>spg-7</italic>) bacteria were provided. GFP expressions were imaged after 48 hr.</p><p>For antimycin A induced UPR<sup>mt</sup>, synchronized L1 worms were raised on 6 cm worm plates for 48 hr. 200 µl of 20 µg/ml antimycin were then provided. Fluorescent images were taken 24 hr after the addition of antimycin.</p><p>For <italic>P. aeruginosa</italic> induced UPR<sup>mt</sup>, synchronized L1 worms were raised on 6 cm worm plates for 24 hr before exposure to <italic>P. aeruginosa.</italic> Worms were imaged at adulthood day 1.</p></sec><sec id="s4-5"><title>Microscopy</title><p>Worms with each indicated fluorescent reporter were dropped in 100 mM NaN3 droplet on 2% agarose pads and imaged with a Zeiss Imager M2 microscopy.</p></sec><sec id="s4-6"><title>Western blotting</title><p>Worms raised under each described condition were washed off plates with M9 buffer and then washed several times with M9 until supernatant was clear. 2X SDS Laemmli buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% bromophenol blue, 0.125M tris-HCl, pH 6.8) was used to re-suspend the worm pellet. Samples were boiled at 95°C for 5 min. Lysates containing the same amount of protein were loaded onto SDS-PAGE and transferred onto PVDF membranes (Bio-Rad). After blocked with 5% non-fat milk, the membrane was probed with the designated first and second antibodies (mouse monoclonal anti-GFP, sungen biotech #KM8009; rabbit polyclonal anti-GFP, abcam #ab290; anti-Myc, CST #2276; anti-tubulin, abcam #ab6161; anti-UBC9, abcam #ab75854; anti-ATFS-1, anti-DVE-1 and anti-SMO-1 antibodies were developed by abclonal), developed with the enhanced chemiluminescence method (Pierce, CAT#32106), and visualized by Tanon 5200 chemical luminescence imaging system. The result analysis was performed by ImageCal (Tanon).</p></sec><sec id="s4-7"><title>Immunoprecipitation</title><p>293 T cells in 10 cm plate were transfected with 3 µg EGFP-SMO-1, 2 µg UBC9, 5 µg MYC-DVE-1 or MYC-ATFS-1<sup>△1-32</sup> plasmids via lipofectamine 3000 (Invitrogen, CAT#L3000015) or PEI. For ULP-4 deSUMOylation assay, additional 5 µg MYC-ULP-4 C48 plasmid was co-transfected. 24 hr after transfection, cells were washed with 1X PBS buffer, scraped off the plates and pelleted by centrifugation at 1000 rpm for 1 min. Immunoprecipitation was performed at 4°C or on ice. Cell pellet was resuspended in 1 ml lysis buffer (50 mM tris-HCl pH 7.5, 150 mM NaCl, 1% NP40, 1 mM EDTA, 1 mM EGTA, 20 mM N-Ethylmaleimide, proteinase inhibitor cocktail) and sonicated. Samples were spun down at 21,000 g for 15 min. Supernatants were transferred into new tubes. Protein concentration was quantitated by BCA assay (Thermo, CAT#23225). Same amount of protein wasused for immunoprecipitation with appropriate antibodies. Samples were incubated with agitation at 4°C for 4 hr. 20 µl pre-washed protein G beads (Invitrogen, CAT#10004D) were added to each sample and rotated for additional 2 hr at 4°C. Protein G beads were washed four times with lysis buffer. 50 ul 2X SDS Laemmli (4% SDS, 20% glycerol, 10% 2-mercaptoenthnol, 0.004 bromophenol blue, 0.125M Tri-HCL, pH 6.8) buffer was added to the beads and boiled for 5 min at 95°C.</p></sec><sec id="s4-8"><title>RNA isolation and Q-PCR</title><p>Worms were fed with each indicated RNAi or exposed to pathogen. Adulthood day one worms were washed off plates and washed several times with M9 buffer until supernatant was clear. Worm pellets were re-suspended with TRIzol reagent (cwbiol, CAT#cw0580A). Samples were frozen and thawed six times to crack worms. Total RNA was isolated by chloroform extraction, followed by ethanol precipitation and DNase treatment. cDNA was then synthesized by reverse transcription (transgene biotech, CAT#AT311-03). Quantitative real-time PCR was carried out using SYBR GREEN PCR Master Mix (Bio-Rad, CAT#1725121). Quantification of transcripts was normalized to <italic>act-3</italic>.</p><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th valign="top">Q-PCR primer</th><th valign="top">Sequence (5' --&gt;3')</th></tr></thead><tbody><tr><td valign="top"><italic>cco-1</italic> F</td><td valign="top">TCAGTGAAAATAAAACGCGCT</td></tr><tr><td valign="top"><italic>cco-1</italic> R</td><td valign="top">GTTGTTTCCACCTGTTTTGTTCA</td></tr><tr><td valign="top"><italic>smo-1</italic> F</td><td valign="top">AGAGCAGCTGGGCGGATT</td></tr><tr><td valign="top"><italic>smo-1</italic> R</td><td valign="top">CCGAAAACGAAGAGTTTATTTGTAAGATAAATA</td></tr><tr><td valign="top"><italic>spg-7</italic> F</td><td valign="top">CGCCGAACCCGTGATCTATT</td></tr><tr><td valign="top"><italic>spg-7</italic> R</td><td valign="top">GAGTCCTCCGGTACCTGAG</td></tr><tr><td valign="top"><italic>ubc-9</italic> F</td><td valign="top">GTCCATGGGCTGAGTAGTCT</td></tr><tr><td valign="top"><italic>ubc-9</italic> R</td><td valign="top">GGAATACACGGGATTTGTCAACA</td></tr><tr><td valign="top"><italic>ulp-1</italic> F</td><td valign="top">GCAATGGCGATTCGAAATATCC</td></tr><tr><td valign="top"><italic>ulp-1</italic> R</td><td valign="top">TCCAAGATGAACTGGCACCA</td></tr><tr><td valign="top"><italic>ulp-2</italic> F</td><td valign="top">TGGTCAAAGTTCTTCCCGGA</td></tr><tr><td valign="top"><italic>ulp-2</italic> R</td><td valign="top">CACTGCACTATGACGACGTG</td></tr><tr><td valign="top"><italic>ulp-4</italic> F</td><td valign="top">GCTTTCACCCTCTTGCTACA</td></tr><tr><td valign="top"><italic>ulp-4</italic> R</td><td valign="top">AATCAACCGAGGCGCTAGTA</td></tr><tr><td valign="top"><italic>ulp-5</italic> F</td><td valign="top">CCTCATCCTAAGCTCACTCCA</td></tr><tr><td valign="top"><italic>ulp-5</italic> R</td><td valign="top">ACACTTCCAAACGCATCCAA</td></tr><tr><td valign="top"><italic>aos-1</italic> F</td><td valign="top">ATGTGCAATTTCCCACCAGT</td></tr><tr><td valign="top"><italic>aos-1</italic> R</td><td valign="top">ACACCGATATTCACACCAAGA</td></tr><tr><td valign="top"><italic>hsp-16.2</italic> F</td><td valign="top">TCCAGTCTGCAGAATCTCTCC</td></tr><tr><td valign="top"><italic>hsp-16.2</italic> R</td><td valign="top">TGCACCAACATCTACATCTTCAG</td></tr><tr><td valign="top"><italic>hsp-4</italic> F</td><td valign="top">CTCGGAGGAAAGCTCACTGA</td></tr><tr><td valign="top"><italic>hsp-4</italic> R</td><td valign="top">ATGGCTCCTCAGAAGCTTGT</td></tr><tr><td valign="top"><italic>atp-2</italic> F</td><td valign="top">CAAGTCGCTGAGGTGTTCAC</td></tr><tr><td valign="top"><italic>atp-2</italic> R</td><td valign="top">CTTCGGCCTTCTTGAACACA</td></tr><tr><td valign="top"><italic>pink-1</italic> F</td><td valign="top">GTTGCAAAAGGTGGACGACT</td></tr><tr><td valign="top"><italic>pink-1</italic> R</td><td valign="top">AAATGGCCGGAAAACTCGAC</td></tr><tr><td valign="top"><italic>hsp-6</italic> F</td><td valign="top">TCCCAAGTCTTCTCTACCGC</td></tr><tr><td valign="top"><italic>hsp-6</italic> R</td><td valign="top">CACGATCTCTGGCTGAAACG</td></tr><tr><td valign="top"><italic>ugt-61</italic> F</td><td valign="top">GCAATTGGAGGTCATGACGTAACTATG</td></tr><tr><td valign="top"><italic>ugt-61</italic> R</td><td valign="top">GCGAAGAATGATTCGGCATCCATCTTG</td></tr><tr><td valign="top"><italic>cyp-14A3</italic> F</td><td valign="top">CAGTTTCCCGCCGAAAACATCCATTTG</td></tr><tr><td valign="top"><italic>cyp-14A3</italic> R</td><td valign="top">CAATGCCGTTCTTCTTTGAAGCCTCCAG</td></tr><tr><td valign="top"><italic>act-3</italic> F</td><td valign="top">TCCCTCGAGAAGTCCTACGA</td></tr><tr><td valign="top"><italic>act-3</italic> R</td><td valign="top">TCCTGGGTACATGGTGGTTC</td></tr><tr><td valign="top"><italic>clec-4</italic> F</td><td valign="top">GAGCGACACTGGTGACTGTG</td></tr><tr><td valign="top"><italic>clec-4</italic> R</td><td valign="top">CCATCCAGAATAGGTTGGCG</td></tr><tr><td valign="top"><italic>lys-2</italic> F</td><td valign="top">ATCGACTCGAACCAAGCTGCG</td></tr><tr><td valign="top"><italic>lys-2</italic> R</td><td valign="top">TCGACAGCATTTCCCATTGAAGCGT</td></tr><tr><td valign="top"><italic>zip-2</italic> F</td><td valign="top">TCGACGAGCAAACGACCTAC</td></tr><tr><td valign="top"><italic>zip-2</italic> R</td><td valign="top">CTTGTGGCGTGCTCATGTT</td></tr><tr><td valign="top"><italic>clec-65</italic> F</td><td valign="top">CCCGGTGGTGACTGTGAATA</td></tr><tr><td valign="top"><italic>clec-65</italic> R</td><td valign="top">AGCTCATATTGTCGCTGGCA</td></tr><tr><td valign="top"><italic>gpd-2</italic> F</td><td valign="top">TGAAATCCAATGGGGAGCCTC</td></tr><tr><td valign="top"><italic>gpd-2</italic> R</td><td valign="top">GGAGCAGAGATGATGACCTTCTTG</td></tr><tr><td valign="top"><italic>gst-14</italic> F</td><td valign="top">GCTACCTTGCTAGAAAATTCGG</td></tr><tr><td valign="top"><italic>gst-14</italic> R</td><td valign="top">GCCGTTAACTTTTCCAGTTCTT</td></tr></tbody></table></table-wrap></sec><sec id="s4-9"><title>Yeast two-hybrid</title><p>Each indicated gene was cloned into pGADT7 or pGBDT7 plasmid (Clontech). Plasmids were then transformed into AH109 yeast strain. We first seeded yeast on –Trp and -Leu double dropout solid culture medium. After yeast colonies were formed, we picked individual yeast colony into sterile water, adjusted it to the same OD and dropped onto -Trp, -Leu, -His and -Ade four dropout solid culture medium. Images of yeast were taken after culturing at 30°C for 2–4 days.</p></sec><sec id="s4-10"><title>Yeast two-hybrid screen</title><p>Full-length <italic>dve-1</italic> was cloned into pGBDT7, and transformed into AH109 yeast strain to test for auto-activation and protein expression. We then transformed <italic>C. elegans</italic> AD library plasmids into yeast that already contains <italic>dve-1</italic> BD plasmid. Yeasts were seeded onto four dropout solid culture medium and grown at 30°C for a week. Each colony was picked, followed by mini-prep to extract AD plasmid for PCR and sequencing.</p></sec><sec id="s4-11"><title>Yeast three-hybrid</title><p>Yeast three-hybrid for DVE-1 deSUMOylation were carried out using pBRIDGE and pGADT7 vectors. <italic>smo-1</italic> was cloned into pGADT7. <italic>dve-1</italic> alone, or together with <italic>ulp-4/5</italic>, were cloned into pBRIDGE. pGADT7 and pBRIDGE plasmids were transformed into AH109 strain and cultured on -Leu and -Trp double dropout solid culture medium for yeast growth, on -Leu, -Trp and -His dropout medium for SMO-1 and DVE-1 interaction assay, on -Met, -Leu, -Trp and -His dropout medium to induce the expression of ULP-4 or ULP-5 and test for deSUMOylation activity.</p></sec><sec id="s4-12"><title>MG132 treatment of worms</title><p>Worms were grown on control or <italic>ulp-4</italic> RNAi plates for 48 hr before heat shock at 37°C for 1 hr. The worms were then transferred in M9 containing indicated RNAi bacteria and 100uM MG132. Images were taken after 24 hr.</p></sec><sec id="s4-13"><title>Transcriptional activity assay</title><p>Each indicated gene was cloned into pCMV-BD vector. We then transfected 0.5 µg pCMV-BD, 0.5 µg pFR-luci (<italic>Photinus pyralis</italic>) and 0.1 µg pActin-luci (<italic>Renilla reniformis</italic>) into one 24-well of 293 T cells. 24 hr after transfection, we assayed luciferase activity with dual luciferase reporter assay system (Promega, CAT#1910).</p></sec><sec id="s4-14"><title>Developmental delay and survival assay</title><p>To assay developmental delay induced by <italic>P. aeruginosa</italic>, worms were pre-treated with control or <italic>ulp-4</italic> RNAi at 20°C for 16 hr. <italic>P. aeruginosa</italic> was then dropped onto worm plates. Images were taken two days later.</p><p>To assay survival rate of worms under antimycin treatment, worms were grown at 20°C on 6-well RNAi plates seeded with control or <italic>ulp-4</italic> RNAi. After 48 hr, 20 µg antimycin A were provided.</p></sec><sec id="s4-15"><title>Lifespan analysis</title><p>Lifespan analyses were conducted on RNAi plates at 20°C. More than 100 synchronized L1 were seeded onto 6 cm worm plates with control or <italic>ulp-4</italic> RNAi. Animals that did not move when gently touched were scored as dead. Worms were transferred every 2 days to new plates during the first 10 days and were transferred every 3–5 days afterwards. Lifespan experiments were performed twice.</p></sec><sec id="s4-16"><title>PA14 survival assay</title><p>PA14 survival assay was carried out as described previously (<xref ref-type="bibr" rid="bib18">Kirienko et al., 2014</xref>). PA14 was freshly streaked from frozen stock and cultured 37°C for 16 hr. 10 µL PA14 were then spread onto 3.5 cm slow killing agar plates (3.5 mg/mL peptone, 3 mg/mL NaCl, 17 mg/mL Agar, 1 mM MgSO4, 25 mM 1MKH2PO4, pH 6, 1 mM CaCla, 5 µg/mL cholesterol). The slow killing plates seeded with PA14 were cultured at 37°C for 24 hr. FUDR was spread on the plates and L4 worms were picked onto plates and cultured at 25°C. Worms were scored at least three times per day after16 hours, until all worms were dead. PA14 survival assay was performed 2 times with three replications each time.</p></sec><sec id="s4-17"><title>CRISPR/Cas9 knock-in</title><p>The pDD162 CRISPR/Cas9 expression plasmid was obtained from Addgene (#47549). <italic>C. elegans</italic> Cas9 target prediction tool (<ext-link ext-link-type="uri" xlink:href="https://crispr.cos.uni-heidelberg.de">https://crispr.cos.uni-heidelberg.de</ext-link>) was used to design target sequences. Templates for recombination were cloned into pDD49.26 vector with ~500 bp overhang upstream and downstream of the target. Cas9 pam sequences were mutated in the templates. The plasmid was injected into worms, with Cas9-<italic>rol-6</italic> as co-injection marker. Rolling worms were singled and validated by PCR and sequencing.</p><p>Primers: <italic>dve-1 K327R</italic> F: TTTCCATCAATATTCGACCAGAACCGG</p><p><italic>dve-1 K327R</italic> R: CGAATATTGATGGAAAACAAAGTATCTTGAATAGTTTC.</p><p><italic>atfs-1 K326R</italic> F: TTTTAAGCGTCCAGAAGCATTTTTCCGGGAAGAACCCATG</p><p><italic>atfs-1 K326R</italic> R: CGGAAAAATGCTTCTGGACGCTTAAAAACGTC</p></sec><sec id="s4-18"><title>Quantification and statistical analysis</title><p>All experiments in this paper, if not specifically indicated, have been repeated for at least three times. Statistical analysis was performed with GraphPad. DVE-1 subcellular localization, transcriptional activity assay, QPCR and worm length were analyzed by Student’s t-test. PA14 survival and lifespan assays were analyzed using Log-Rank method. *p&lt;0.05, **p&lt;0.002 and ***p&lt;0.0002.</p><p>Worm lengths, relative gfp expression and immunoblot quantification were analyzed by Image J. DVE-1 subcellular localization was counted in more than 40 worms per plate and three independent replicates were analyzed for each condition. Transcriptional activity assay wasanalyzed with three independent replicates for each condition. PA14 survival assay was performed with more than 35 worms per plate and at least two independent replicates were analyzed for each condition. The experiment was repeated for at least two times. Lifespan assay was performed with two biological replicates.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Cole Haynes for providing <italic>C. elegans</italic> strains and plasmid, and Dr. Xin-Hua Feng for his generous gifts of plasmids. Several <italic>C. elegans</italic> strains used in this work were provided by the National Bio-Resource Project, and the Caenorhabditis Genetics Center, which is supported by the NIH-Officer of Research Infrastructure Programs P40 OD010440. This work is supported by the National Natural Science Foundation of China (grants 91854205 and 31422033), the Ministry of Science and Technology of China (National Key Research and Development Program of China grant 2017YFA0504000973), Peking-Tsinghua Center for Life Sciences, and an HHMI International Research Scholar Award (HHMI#55008739) to YL.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Methodology, Writing—original draft</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con4"><p>Supervision, Funding acquisition, Investigation, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.41792.017</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-41792-transrepform-v2.docx"/></supplementary-material><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files.</p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreux</surname> <given-names>PA</given-names></name><name><surname>Houtkooper</surname> <given-names>RH</given-names></name><name><surname>Auwerx</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Pharmacological approaches to restore mitochondrial function</article-title><source>Nature Reviews Drug Discovery</source><volume>12</volume><fpage>465</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1038/nrd4023</pub-id><pub-id pub-id-type="pmid">23666487</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benedetti</surname> <given-names>C</given-names></name><name><surname>Haynes</surname> <given-names>CM</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Harding</surname> <given-names>HP</given-names></name><name><surname>Ron</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ubiquitin-like protein 5 positively regulates chaperone gene expression in the mitochondrial unfolded protein response</article-title><source>Genetics</source><volume>174</volume><fpage>229</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1534/genetics.106.061580</pub-id><pub-id pub-id-type="pmid">16816413</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>S</given-names></name><name><surname>Han</surname> <given-names>HJ</given-names></name><name><surname>Kohwi-Shigematsu</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Tissue-specific nuclear architecture and gene expression regulated by SATB1</article-title><source>Nature Genetics</source><volume>34</volume><fpage>42</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1038/ng1146</pub-id><pub-id pub-id-type="pmid">12692553</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chymkowitch</surname> <given-names>P</given-names></name><name><surname>Nguéa P</surname> <given-names>A</given-names></name><name><surname>Enserink</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>SUMO-regulated transcription: challenging the dogma</article-title><source>BioEssays</source><volume>37</volume><fpage>1095</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.1002/bies.201500065</pub-id><pub-id pub-id-type="pmid">26354225</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname> <given-names>V</given-names></name><name><surname>Scorrano</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Shaping the role of mitochondria in the pathogenesis of Huntington's disease</article-title><source>The EMBO Journal</source><volume>31</volume><fpage>1853</fpage><lpage>1864</lpage><pub-id pub-id-type="doi">10.1038/emboj.2012.65</pub-id><pub-id pub-id-type="pmid">22446390</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobreva</surname> <given-names>G</given-names></name><name><surname>Dambacher</surname> <given-names>J</given-names></name><name><surname>Grosschedl</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression</article-title><source>Genes &amp; Development</source><volume>17</volume><fpage>3048</fpage><lpage>3061</lpage><pub-id pub-id-type="doi">10.1101/gad.1153003</pub-id><pub-id pub-id-type="pmid">14701874</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durieux</surname> <given-names>J</given-names></name><name><surname>Wolff</surname> <given-names>S</given-names></name><name><surname>Dillin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The cell-non-autonomous nature of electron transport chain-mediated longevity</article-title><source>Cell</source><volume>144</volume><fpage>79</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.12.016</pub-id><pub-id pub-id-type="pmid">21215371</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estes</surname> <given-names>KA</given-names></name><name><surname>Dunbar</surname> <given-names>TL</given-names></name><name><surname>Powell</surname> <given-names>JR</given-names></name><name><surname>Ausubel</surname> <given-names>FM</given-names></name><name><surname>Troemel</surname> <given-names>ER</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>bZIP transcription factor zip-2 mediates an early response to Pseudomonas aeruginosa infection in Caenorhabditis elegans</article-title><source>PNAS</source><volume>107</volume><fpage>2153</fpage><lpage>2158</lpage><pub-id pub-id-type="doi">10.1073/pnas.0914643107</pub-id><pub-id pub-id-type="pmid">20133860</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiorese</surname> <given-names>CJ</given-names></name><name><surname>Schulz</surname> <given-names>AM</given-names></name><name><surname>Lin</surname> <given-names>YF</given-names></name><name><surname>Rosin</surname> <given-names>N</given-names></name><name><surname>Pellegrino</surname> <given-names>MW</given-names></name><name><surname>Haynes</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Transcription Factor ATF5 Mediates a Mammalian Mitochondrial UPR</article-title><source>Current Biology</source><volume>26</volume><fpage>2037</fpage><lpage>2043</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2016.06.002</pub-id><pub-id pub-id-type="pmid">27426517</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flotho</surname> <given-names>A</given-names></name><name><surname>Melchior</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sumoylation: a regulatory protein modification in health and disease</article-title><source>Annual Review of Biochemistry</source><volume>82</volume><fpage>357</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-061909-093311</pub-id><pub-id pub-id-type="pmid">23746258</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?</article-title><source>Genes &amp; Development</source><volume>18</volume><fpage>2046</fpage><lpage>2059</lpage><pub-id pub-id-type="doi">10.1101/gad.1214604</pub-id><pub-id pub-id-type="pmid">15342487</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hay</surname> <given-names>RT</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>SUMO: a history of modification</article-title><source>Molecular cell</source><volume>18</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.03.012</pub-id><pub-id pub-id-type="pmid">15808504</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname> <given-names>CM</given-names></name><name><surname>Petrova</surname> <given-names>K</given-names></name><name><surname>Benedetti</surname> <given-names>C</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Ron</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>ClpP mediates activation of a mitochondrial unfolded protein response in C. elegans</article-title><source>Developmental Cell</source><volume>13</volume><fpage>467</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2007.07.016</pub-id><pub-id pub-id-type="pmid">17925224</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendriks</surname> <given-names>IA</given-names></name><name><surname>D'Souza</surname> <given-names>RC</given-names></name><name><surname>Yang</surname> <given-names>B</given-names></name><name><surname>Verlaan-de Vries</surname> <given-names>M</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name><name><surname>Vertegaal</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Uncovering global SUMOylation signaling networks in a site-specific manner</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>21</volume><fpage>927</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2890</pub-id><pub-id pub-id-type="pmid">25218447</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houtkooper</surname> <given-names>RH</given-names></name><name><surname>Mouchiroud</surname> <given-names>L</given-names></name><name><surname>Ryu</surname> <given-names>D</given-names></name><name><surname>Moullan</surname> <given-names>N</given-names></name><name><surname>Katsyuba</surname> <given-names>E</given-names></name><name><surname>Knott</surname> <given-names>G</given-names></name><name><surname>Williams</surname> <given-names>RW</given-names></name><name><surname>Auwerx</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mitonuclear protein imbalance as a conserved longevity mechanism</article-title><source>Nature</source><volume>497</volume><fpage>451</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1038/nature12188</pub-id><pub-id pub-id-type="pmid">23698443</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jovaisaite</surname> <given-names>V</given-names></name><name><surname>Mouchiroud</surname> <given-names>L</given-names></name><name><surname>Auwerx</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The mitochondrial unfolded protein response, a conserved stress response pathway with implications in health and disease</article-title><source>Journal of Experimental Biology</source><volume>217</volume><fpage>137</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1242/jeb.090738</pub-id><pub-id pub-id-type="pmid">24353213</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname> <given-names>K</given-names></name><name><surname>Standley</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MAFFT multiple sequence alignment software version 7: improvements in performance and usability</article-title><source>Molecular Biology and Evolution</source><volume>30</volume><fpage>772</fpage><lpage>780</lpage><pub-id pub-id-type="doi">10.1093/molbev/mst010</pub-id><pub-id pub-id-type="pmid">23329690</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirienko</surname> <given-names>NV</given-names></name><name><surname>Cezairliyan</surname> <given-names>BO</given-names></name><name><surname>Ausubel</surname> <given-names>FM</given-names></name><name><surname>Powell</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pseudomonas aeruginosa PA14 pathogenesis in Caenorhabditis elegans</article-title><source>Methods in molecular biology</source><volume>1149</volume><fpage>653</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-0473-0_50</pub-id><pub-id pub-id-type="pmid">24818940</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Ozcan</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Unfolded protein response signaling and metabolic diseases</article-title><source>Journal of Biological Chemistry</source><volume>289</volume><fpage>1203</fpage><lpage>1211</lpage><pub-id pub-id-type="doi">10.1074/jbc.R113.534743</pub-id><pub-id pub-id-type="pmid">24324257</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letunic</surname> <given-names>I</given-names></name><name><surname>Bork</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>20 years of the SMART protein domain annotation resource</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>D493</fpage><lpage>D496</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx922</pub-id><pub-id pub-id-type="pmid">29040681</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Samuel</surname> <given-names>BS</given-names></name><name><surname>Breen</surname> <given-names>PC</given-names></name><name><surname>Ruvkun</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Caenorhabditis elegans pathways that surveil and defend mitochondria</article-title><source>Nature</source><volume>508</volume><fpage>406</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1038/nature13204</pub-id><pub-id pub-id-type="pmid">24695221</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melo</surname> <given-names>JA</given-names></name><name><surname>Ruvkun</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Inactivation of conserved C. elegans genes engages pathogen- and xenobiotic-associated defenses</article-title><source>Cell</source><volume>149</volume><fpage>452</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.02.050</pub-id><pub-id pub-id-type="pmid">22500807</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merkwirth</surname> <given-names>C</given-names></name><name><surname>Jovaisaite</surname> <given-names>V</given-names></name><name><surname>Durieux</surname> <given-names>J</given-names></name><name><surname>Matilainen</surname> <given-names>O</given-names></name><name><surname>Jordan</surname> <given-names>SD</given-names></name><name><surname>Quiros</surname> <given-names>PM</given-names></name><name><surname>Steffen</surname> <given-names>KK</given-names></name><name><surname>Williams</surname> <given-names>EG</given-names></name><name><surname>Mouchiroud</surname> <given-names>L</given-names></name><name><surname>Tronnes</surname> <given-names>SU</given-names></name><name><surname>Murillo</surname> <given-names>V</given-names></name><name><surname>Wolff</surname> <given-names>SC</given-names></name><name><surname>Shaw</surname> <given-names>RJ</given-names></name><name><surname>Auwerx</surname> <given-names>J</given-names></name><name><surname>Dillin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Two conserved histone demethylases regulate mitochondrial stress-induced longevity</article-title><source>Cell</source><volume>165</volume><fpage>1209</fpage><lpage>1223</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.012</pub-id><pub-id pub-id-type="pmid">27133168</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mo</surname> <given-names>YY</given-names></name><name><surname>Yu</surname> <given-names>Y</given-names></name><name><surname>Theodosiou</surname> <given-names>E</given-names></name><name><surname>Ee</surname> <given-names>PL</given-names></name><name><surname>Beck</surname> <given-names>WT</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A role for Ubc9 in tumorigenesis</article-title><source>Oncogene</source><volume>24</volume><fpage>2677</fpage><lpage>2683</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1208210</pub-id><pub-id pub-id-type="pmid">15735760</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukhopadhyay</surname> <given-names>D</given-names></name><name><surname>Dasso</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Modification in reverse: the SUMO proteases</article-title><source>Trends in Biochemical Sciences</source><volume>32</volume><fpage>286</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2007.05.002</pub-id><pub-id pub-id-type="pmid">17499995</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nargund</surname> <given-names>AM</given-names></name><name><surname>Pellegrino</surname> <given-names>MW</given-names></name><name><surname>Fiorese</surname> <given-names>CJ</given-names></name><name><surname>Baker</surname> <given-names>BM</given-names></name><name><surname>Haynes</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation</article-title><source>Science</source><volume>337</volume><fpage>587</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1126/science.1223560</pub-id><pub-id pub-id-type="pmid">22700657</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nargund</surname> <given-names>AM</given-names></name><name><surname>Fiorese</surname> <given-names>CJ</given-names></name><name><surname>Pellegrino</surname> <given-names>MW</given-names></name><name><surname>Deng</surname> <given-names>P</given-names></name><name><surname>Haynes</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mitochondrial and nuclear accumulation of the transcription factor ATFS-1 promotes OXPHOS recovery during the UPR(mt)</article-title><source>Molecular Cell</source><volume>58</volume><fpage>123</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.02.008</pub-id><pub-id pub-id-type="pmid">25773600</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panov</surname> <given-names>AV</given-names></name><name><surname>Gutekunst</surname> <given-names>CA</given-names></name><name><surname>Leavitt</surname> <given-names>BR</given-names></name><name><surname>Hayden</surname> <given-names>MR</given-names></name><name><surname>Burke</surname> <given-names>JR</given-names></name><name><surname>Strittmatter</surname> <given-names>WJ</given-names></name><name><surname>Greenamyre</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines</article-title><source>Nature Neuroscience</source><volume>5</volume><fpage>731</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1038/nn884</pub-id><pub-id pub-id-type="pmid">12089530</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrino</surname> <given-names>MW</given-names></name><name><surname>Nargund</surname> <given-names>AM</given-names></name><name><surname>Haynes</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Signaling the mitochondrial unfolded protein response</article-title><source>Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</source><volume>1833</volume><fpage>410</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2012.02.019</pub-id><pub-id pub-id-type="pmid">22445420</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrino</surname> <given-names>MW</given-names></name><name><surname>Nargund</surname> <given-names>AM</given-names></name><name><surname>Kirienko</surname> <given-names>NV</given-names></name><name><surname>Gillis</surname> <given-names>R</given-names></name><name><surname>Fiorese</surname> <given-names>CJ</given-names></name><name><surname>Haynes</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mitochondrial UPR-regulated innate immunity provides resistance to pathogen infection</article-title><source>Nature</source><volume>516</volume><fpage>414</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1038/nature13818</pub-id><pub-id pub-id-type="pmid">25274306</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prudent</surname> <given-names>J</given-names></name><name><surname>Zunino</surname> <given-names>R</given-names></name><name><surname>Sugiura</surname> <given-names>A</given-names></name><name><surname>Mattie</surname> <given-names>S</given-names></name><name><surname>Shore</surname> <given-names>GC</given-names></name><name><surname>McBride</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MAPL SUMOylation of Drp1 Stabilizes an ER/mitochondrial platform required for cell death</article-title><source>Molecular Cell</source><volume>59</volume><fpage>941</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.08.001</pub-id><pub-id pub-id-type="pmid">26384664</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname> <given-names>J</given-names></name><name><surname>Gao</surname> <given-names>X</given-names></name><name><surname>Jin</surname> <given-names>C</given-names></name><name><surname>Zhu</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Shaw</surname> <given-names>A</given-names></name><name><surname>Wen</surname> <given-names>L</given-names></name><name><surname>Yao</surname> <given-names>X</given-names></name><name><surname>Xue</surname> <given-names>Y</given-names></name><name><surname>Jian</surname> <given-names>R</given-names></name><name><surname>Xinjiao</surname> <given-names>G</given-names></name><name><surname>Changjiang</surname> <given-names>J</given-names></name><name><surname>Mei</surname> <given-names>Z</given-names></name><name><surname>Xiwei</surname> <given-names>W</given-names></name><name><surname>Andrew</surname> <given-names>S</given-names></name><name><surname>Yu</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Systematic study of protein sumoylation: Development of a site-specific predictor of SUMOsp 2.0</article-title><source>Proteomics</source><volume>9</volume><fpage>3409</fpage><lpage>3412</lpage><pub-id pub-id-type="doi">10.1002/pmic.200800646</pub-id><pub-id pub-id-type="pmid">29658196</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapir</surname> <given-names>A</given-names></name><name><surname>Tsur</surname> <given-names>A</given-names></name><name><surname>Koorman</surname> <given-names>T</given-names></name><name><surname>Ching</surname> <given-names>K</given-names></name><name><surname>Mishra</surname> <given-names>P</given-names></name><name><surname>Bardenheier</surname> <given-names>A</given-names></name><name><surname>Podolsky</surname> <given-names>L</given-names></name><name><surname>Bening-Abu-Shach</surname> <given-names>U</given-names></name><name><surname>Boxem</surname> <given-names>M</given-names></name><name><surname>Chou</surname> <given-names>TF</given-names></name><name><surname>Broday</surname> <given-names>L</given-names></name><name><surname>Sternberg</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Controlled sumoylation of the mevalonate pathway enzyme HMGS-1 regulates metabolism during aging</article-title><source>PNAS</source><volume>111</volume><fpage>E3880</fpage><lpage>E3889</lpage><pub-id pub-id-type="doi">10.1073/pnas.1414748111</pub-id><pub-id pub-id-type="pmid">25187565</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarge</surname> <given-names>KD</given-names></name><name><surname>Park-Sarge</surname> <given-names>OK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Sumoylation and human disease pathogenesis</article-title><source>Trends in Biochemical Sciences</source><volume>34</volume><fpage>200</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2009.01.004</pub-id><pub-id pub-id-type="pmid">19282183</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname> <given-names>CA</given-names></name><name><surname>Rasband</surname> <given-names>WS</given-names></name><name><surname>Eliceiri</surname> <given-names>KW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NIH image to ImageJ: 25 years of image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>671</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2089</pub-id><pub-id pub-id-type="pmid">22930834</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seeler</surname> <given-names>JS</given-names></name><name><surname>Bischof</surname> <given-names>O</given-names></name><name><surname>Nacerddine</surname> <given-names>K</given-names></name><name><surname>Dejean</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>SUMO, the three rs and cancer</article-title><source>Current Topics in Microbiology and Immunology</source><volume>313</volume><fpage>49</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">17217038</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steffan</surname> <given-names>JS</given-names></name><name><surname>Agrawal</surname> <given-names>N</given-names></name><name><surname>Pallos</surname> <given-names>J</given-names></name><name><surname>Rockabrand</surname> <given-names>E</given-names></name><name><surname>Trotman</surname> <given-names>LC</given-names></name><name><surname>Slepko</surname> <given-names>N</given-names></name><name><surname>Illes</surname> <given-names>K</given-names></name><name><surname>Lukacsovich</surname> <given-names>T</given-names></name><name><surname>Zhu</surname> <given-names>YZ</given-names></name><name><surname>Cattaneo</surname> <given-names>E</given-names></name><name><surname>Pandolfi</surname> <given-names>PP</given-names></name><name><surname>Thompson</surname> <given-names>LM</given-names></name><name><surname>Marsh</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>SUMO modification of Huntingtin and Huntington's disease pathology</article-title><source>Science</source><volume>304</volume><fpage>100</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1126/science.1092194</pub-id><pub-id pub-id-type="pmid">15064418</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>JA</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Song</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Krontiris</surname> <given-names>TG</given-names></name><name><surname>Durrin</surname> <given-names>LK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>SUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavage</article-title><source>Journal of Biological Chemistry</source><volume>283</volume><fpage>18124</fpage><lpage>18134</lpage><pub-id pub-id-type="doi">10.1074/jbc.M800512200</pub-id><pub-id pub-id-type="pmid">18408014</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname> <given-names>Y</given-names></name><name><surname>Garcia</surname> <given-names>G</given-names></name><name><surname>Bian</surname> <given-names>Q</given-names></name><name><surname>Steffen</surname> <given-names>KK</given-names></name><name><surname>Joe</surname> <given-names>L</given-names></name><name><surname>Wolff</surname> <given-names>S</given-names></name><name><surname>Meyer</surname> <given-names>BJ</given-names></name><name><surname>Dillin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitochondrial stress induces chromatin reorganization to promote longevity and UPR(mt)</article-title><source>Cell</source><volume>165</volume><fpage>1197</fpage><lpage>1208</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.011</pub-id><pub-id pub-id-type="pmid">27133166</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsur</surname> <given-names>A</given-names></name><name><surname>Bening Abu-Shach</surname> <given-names>U</given-names></name><name><surname>Broday</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ULP-2 SUMO protease regulates E-Cadherin recruitment to adherens junctions</article-title><source>Developmental Cell</source><volume>35</volume><fpage>63</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2015.08.019</pub-id><pub-id pub-id-type="pmid">26412237</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Kaufman</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The impact of the unfolded protein response on human disease</article-title><source>The Journal of Cell Biology</source><volume>197</volume><fpage>857</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1083/jcb.201110131</pub-id><pub-id pub-id-type="pmid">22733998</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasiak</surname> <given-names>S</given-names></name><name><surname>Zunino</surname> <given-names>R</given-names></name><name><surname>McBride</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death</article-title><source>The Journal of Cell Biology</source><volume>177</volume><fpage>439</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1083/jcb.200610042</pub-id><pub-id pub-id-type="pmid">17470634</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname> <given-names>ET</given-names></name><name><surname>Gong</surname> <given-names>L</given-names></name><name><surname>Kamitani</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Ubiquitin-like proteins: new wines in new bottles</article-title><source>Gene</source><volume>248</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/S0378-1119(00)00139-6</pub-id><pub-id pub-id-type="pmid">10806345</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoneda</surname> <given-names>T</given-names></name><name><surname>Benedetti</surname> <given-names>C</given-names></name><name><surname>Urano</surname> <given-names>F</given-names></name><name><surname>Clark</surname> <given-names>SG</given-names></name><name><surname>Harding</surname> <given-names>HP</given-names></name><name><surname>Ron</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones</article-title><source>Journal of Cell Science</source><volume>117</volume><fpage>4055</fpage><lpage>4066</lpage><pub-id pub-id-type="doi">10.1242/jcs.01275</pub-id><pub-id pub-id-type="pmid">15280428</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>Q</given-names></name><name><surname>Xie</surname> <given-names>Y</given-names></name><name><surname>Zheng</surname> <given-names>Y</given-names></name><name><surname>Jiang</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>W</given-names></name><name><surname>Mu</surname> <given-names>W</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Xue</surname> <given-names>Y</given-names></name><name><surname>Ren</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>W325</fpage><lpage>W330</lpage><pub-id pub-id-type="doi">10.1093/nar/gku383</pub-id><pub-id pub-id-type="pmid">24880689</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.41792.018</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Zhang</surname><given-names>Hong</given-names></name><role>Reviewing Editor</role><aff><institution>Institute of Biophysics, Chinese Academy of Sciences</institution><country>China</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;SUMO peptidase ULP-4 regulates mitochondrial UPR-mediated innate immunity and lifespan extension&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Ivan Dikic as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Hui Jiang (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>In <italic>C. elegans</italic>, mitochondrial stresses trigger mitochondrial unfolded protein response (UPR<sup>mt</sup>) through two transcription factors: DVE-1 and ATFS-1. The signaling cascade from mitochondrial stress to transcription response is incompletely understood. In this manuscript, Gao and colleagues report that SUMO peptidase ULP-4 is critical for UPR<sup>mt</sup> activation and UPR<sup>mt</sup>-regulated innate immunity and lifespan extension. The authors identify DVE-1 and ATFS-1 as SUMOylated proteins that are deSUMOylated by ULP-4. In the absence of ULP-4, SUMOylated DVE-1 remains in the cytoplasm and SUMOylated ATFS-1 becomes unstable and has reduced transcription activity. Overall, the finding that ULP-4 controls UPR<sup>mt</sup> in worms is striking and of considerable interest. Particularly, the genetic evidence with ULP-4 mutants exemplifies the major role ULP-4 appears to play in this pathway. This manuscript is suitable for publication in <italic>eLife</italic> after appropriate revisions.</p><p>Essential revisions:</p><p>1) DVE-1 is SUMOylated at K327 in 293T cells and in worms. ULP-4 deSUMOylates DVE-1 in 293T cells. To fully establish the role of ULP-4 in deSUMOylation of DVE-1 in worms, it is important to examine whether ULP4-RNAi can increase SUMOylation of DVE-1 under normal and stress conditions.</p><p>2) While it is convincing that ULP-4 is required for UPR<sup>mt</sup>, the final model (Figure 7) suggests changes in ULP-4 activity/levels upon mitochondrial stress. Otherwise, deSUMOylation of DVE-1 would also appear under normal conditions. Figure 1—figure supplement 1C suggests a small increase in <italic>ulp-4</italic> mRNA. Do ULP-4 levels increase upon induction of UPR<sup>mt</sup> as potentially suggested in Figure 7? Is overexpression of ULP-4 sufficient to deSUMOylate DVE-1 and drive its transcriptional activity?</p><p>3) Findings on the destabilization of ATFS-1 by <italic>ulp-4</italic> RNAi are obtained after overexpression of mislocalized ATFS-1<sup>Δ1-184</sup> (which lacks the MTS) and studied upon heat shock, which will perturb many processes in addition to mitochondria. Do endogenous ATFS-1 levels (which is usually mitochondrially localized) also change dependent on <italic>ulp-4</italic> RNAi and mitochondrial stress (e.g. <italic>spg-7</italic> RNAi)?</p><p>4) Despite the genetic evidence for the role of the K327 or K326 residues of DVE-1 or ATFS-1 respectively for UPR<sup>mt</sup> induction, actual SUMOylation of these sites remains unclear. The size shifts observed in experiments for both DVE-1 and ATFS-1 are not consistent with mono-SUMOylation of these residues. However, specific deSUMOylation of K327/K326 or two mono-SUMOylations seem unlikely as the authors ruled out the other predicted SUMOylation sites. The authors should explain the observed shifts and confirm SUMOylation on endogenous DVE-1 and ATFS-1. Alternatively, SUMOylation could be confirmed by a mass spec approach showing modification of these sites (similar as for SUMO, see e.g. Impens et al., 2014).</p><p>References:</p><p>Impens F, Radoshevich L, Cossart P, Ribet D. Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli. PNAS. 2014 Aug 26;111(34):12432-7. doi: 10.1073/pnas.1413825111.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.41792.019</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) DVE-1 is SUMOylated at K327 in 293T cells and in worms. ULP-4 deSUMOylates DVE-1 in 293T cells. To fully establish the role of ULP-4 in deSUMOylation of DVE-1 in worms, it is important to examine whether ULP4-RNAi can increase SUMOylation of DVE-1 under normal and stress conditions.</p></disp-quote><p>We have followed the reviewers’ comments to knockdown <italic>ulp-4</italic> by RNAi and found that <italic>ulp-4</italic> RNAi can increase DVE-1 SUMOylation levels a bit under normal and stress conditions (Figure 2—figure supplement 1D). However, we have to admit that biochemistry on SUMOylation is not easy to do, especially when dealing with worms. Our genetic data is much stronger to support that DVE-1 is the bona fide target of ULP-4 in UPR<sup>mt</sup> signaling. To further support the function of ULP-4 in deSUMOylation of DVE-1, we overexpressed ULP-4 in worms and observed a reduced level of DVE-1 SUMOylation (Figure 2H). In addition, we have also showed that catalytic domain (C48) of ULP-4 could deSUMOylate DVE-1 when co-transfected in 293T cells (Figure 2I).</p><disp-quote content-type="editor-comment"><p>2) While it is convincing that ULP-4 is required for UPR<sup>mt</sup>, the final model (Figure 7) suggests changes in ULP-4 activity/levels upon mitochondrial stress. Otherwise, deSUMOylation of DVE-1 would also appear under normal conditions. Figure 1—figure supplement 1C suggests a small increase in ulp-4 mRNA. Do ULP-4 levels increase upon induction of UPR<sup>mt</sup> as potentially suggested in Figure 7? Is overexpression of ULP-4 sufficient to deSUMOylate DVE-1 and drive its transcriptional activity?</p></disp-quote><p>The induction fold of <italic>ulp-4</italic> transcripts is ~1.5, which is comparable to the induction fold of many other mitochondrial stress response genes such as <italic>hsp-6</italic> and <italic>hsp-60</italic> (Figure 1C and Figure 1—figure supplement 1B). We don’t have antibody to detect protein levels of ULP-4. We also tried very hard to generate <italic>ulp-4p::ulp-4::gfp</italic> strain, but haven’t successfully got this strain yet. To further answer the reviewers’ question, we generated <italic>rpl-28p::ulp-4; dve-1p::dve-1::gfp</italic> strain, and showed that overexpression of ULP-4 is sufficient to drive the nuclear accumulation of DVE-1 (Figure 3D). In addition, overexpression of ULP-4 is sufficient to deSUMOylate DVE-1 (Figure 2H). We also tried to use luciferase assay, similar as those in Figure 5F and 5G, to test transcriptional activity of DVE-1. However, we found that expression of DVE-1 alone in 293T cells could not induce target genes transcription. It suggests that DVE-1 may require other co-factors to exert its transcriptional activity.</p><disp-quote content-type="editor-comment"><p>3) Findings on the destabilization of ATFS-1 by ulp-4 RNAi are obtained after overexpression of mislocalized ATFS-1<sup>Δ1-184</sup> (which lacks the MTS) and studied upon heat shock, which will perturb many processes in addition to mitochondria. Do endogenous ATFS-1 levels (which is usually mitochondrially localized) also change dependent on ulp-4 RNAi and mitochondrial stress (e.g. spg-7 RNAi)?</p></disp-quote><p>We haven’t been able to raise a good ATFS-1 antibody that could detect endogenous ATFS-1 proteins. Therefore, we tried to use an <italic>atfs-1p::atfs-1::gfp</italic> strain and perform western blotting with anti-GFP antibody to detect full-length ATFS-1 proteins. Under normal growth condition, protein level of ATFS-1 is not detectable, because ATFS-1 is imported into mitochondria and degraded by mitochondrial protease LON-1 (Nargund et al., 2012). We fed worms with <italic>lon-1</italic> RNAi and showed that <italic>ulp-4</italic> RNAi reduced protein levels of full-length ATFS-1 (Figure 5C).</p><disp-quote content-type="editor-comment"><p>4) Despite the genetic evidence for the role of the K327 or K326 residues of DVE-1 or ATFS-1 respectively for UPR<sup>mt</sup> induction, actual SUMOylation of these sites remains unclear. The size shifts observed in experiments for both DVE-1 and ATFS-1 are not consistent with mono-SUMOylation of these residues. However, specific deSUMOylation of K327/K326 or two mono-SUMOylations seem unlikely as the authors ruled out the other predicted SUMOylation sites. The authors should explain the observed shifts and confirm SUMOylation on endogenous DVE-1 and ATFS-1. Alternatively, SUMOylation could be confirmed by a mass spec approach showing modification of these sites (similar as for SUMO, see e.g. Ingens et al., 2014).</p></disp-quote><p>We have followed the reviewers’ suggestion to carry out mass spectrometry analysis. However, we failed to detect SUMOylation on DVE-1 and ATFS-1 through mass spec. Mass spectrometry to detect SUMOylation is not as easy as detecting phosphorylation. A more commonly used approach is to employ site-direct mutagenesis to analyze SUMOylation site within the protein-of-interest.</p><p>The size shift might be due to di-SUMOylation on a single lysine residue of the target protein. Similar as ubiquitin, SUMO could also be covalently conjugated and form di- or multi-SUMO chain (Knipsheer et al., 2007; Klug et al., 2013 Molecular Cell; Tatham et al., 2008). To test this idea, we tried to express DVE-1<sup>295-354</sup> or ATFS-1<sup>261-360</sup> fragment, which contains only one lysine residue (DVE-1 K327 or ATFS-1 K326) in 293T cells. Only DVE-1<sup>295-354</sup> expressed well in 293T cells. The size shift of DVE-1<sup>295-354</sup>-3xFLAG upon SMO-1 and UBC9 co-transfection is ~60KDa, similar as the molecular weight of di-EGFP-SUMO (Figure 2—figure supplement 1F). Therefore, we think the size shift that we observed for DVE-1 and ATFS-1 is due to di-SUMO moiety. We have discussed this issue in the revised manuscript.</p><p>References:</p><p>Klug H, Xaver M, Chaugule VK, Koidl S, Mittler G, Klein F, Pichler A. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in <italic>Saccharomyces cerevisiae</italic>. Mol Cell. 2013 Jun 6;50(5):625-36. doi: 10.1016/j.molcel.2013.03.027.</p><p>Knipscheer P, van Dijk WJ, Olsen JV, Mann M, Sixma TK. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation. EMBO J. 2007 Jun 6; 26(11): 2797–2807. doi: 10.1038/sj.emboj.7601711</p><p>Tatham MH1, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, Jaffray EG, Palvimo JJ, Hay RT. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol. 2008 May;10(5):538-46. doi: 10.1038/ncb1716.</p></body></sub-article></article>